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ABSTRACT
Nigeria has some of the highest rates of cervical cancer morbidity and mortality in
sub-Saharan Africa. Both the human papillomavirus vaccine (HPV) and cervical screening
are effective prevention strategies against both HPV infection and cervical cancer. Lack of
awareness, limited knowledge, limited decision-making agency, lack of spousal support
and stigma are barriers to uptake of these preventive measures. Given patriarchal structures
and norms through which men control family resources and dominate decisions, male
involvement in initiatives aimed at improving sexual and reproductive health is necessary.
Community-based health education is an effective intervention to improve knowledge and
reduce stigma. The aim of this research was to evaluate the impact of an
educational intervention on awareness, knowledge, intention to take HPV vaccination and
cervical screening, and reduce stigma among men and women offered at 12 urban
community locations in Nigeria. This is a pre-test and post-test study that employed two
community-based health education interventions; a face-to-face presentation delivered in
group settings and printed pamphlet delivered to individuals. A total of 266 participants
within 18 and 65 years participated.
At baseline, the majority (80%) of all participants had low levels of knowledge of
HPV and HPV vaccine and 21% had limited knowledge of cervical cancer and cervical
screening. The proportion of participants with poor knowledge of HPV and cervical cancer
reduced significantly at post-intervention in both groups. Our results showed that less than
12% of all participants had ever received HPV vaccine and screening.

vi

There was

significant increase in the participants’ intention to take and to encourage a family member
to receive HPV vaccination and cervical cancer screening. Of note, knowledge of HPV as
a sexually transmitted infection was associated with high levels of stigma, which increased
after exposure to the intervention.
The research supported the effectiveness of the community-based educational
intervention in promoting the increasing awareness, knowledge and intention to take HPV
vaccine and cervical screening among urban-dwelling Nigerian adults. Study findings are
important for informing future gender-comprehensive and context-specific programs
activities that seek to engage men in reducing HPV infection and cervical cancer in SubSaharan Africa. Further research is warranted to assess the factors contributing to ongoing
stigma and to develop effective interventions to reduce stigma among Nigerian adults.
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CHAPTER 1
INTRODUCTION
Background
Human Papillomavirus (HPV) refers to small, double-stranded DNA viruses with
more than 150 identified types. Each virus is classified according to their oncogenic
potential into low-risk and high-risk HPV types (Centers for Disease Control and
Prevention, [CDC] 2017). HPV is the most common sexually transmitted infection,
commonly spread through intimate skin-to-skin contact by having vaginal, anal, or oral
sex. HPV transmission from hands to genitals or genitals to hands have also reported for
both sexes and heterosexual couples (Liu, 2016). HPV has been found to be resistant to
heat and desiccation, therefore non-sexual transmission of the virus is possible (Ault,
2006). HPV is so common that most sexually active men and women will be infected with
at least one type of HPV at some point in their lives. It is difficult to detect when an
individual first became infected with HPV as symptoms can develop years after infection
(CDC, 2017).
The vast majority of HPV infection is asymptomatic and will clear without medical
intervention; but those who contract persistent high-risk HPV types may develop cancer.
HPV is estimated to cause about 5% of human cancers (de Martel et al., 2012; Bosch et al,
2013), including anogenital cancers (cervical, vaginal, vulvar, penile, and anal) and
oropharyngeal cancer (CDC, 2017). The prevalence of HPV among general population is
unknown in Nigeria but studies had reported 42.9% of women in a state in the northern
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region (Aminu et al., 2014) and 26.3% of the general population in Southern Nigeria had
HPV-IgG antibodies (Aminu et al., 2014; Bruni et al., 2014; Okolo et al., 2010).
Furthermore, the age-specific prevalence revealed that 52% of Nigerian women ≤ 30 years
had an HPV infection compared to 23% of women who were older than 45 years (AkaroloAnthony et al., 2014).
HPV infection is responsible for more than 90% of cervical cancers (CDC, 2017),
and Nigeria has one of the most extensive epidemics of cervical cancer in sub-Saharan
Africa (Ferlay et al., 2014; Oguntayo et al., 2011). Cervical cancer is the second most
common female cancer in many parts of Nigeria (Oguntayo et al., 2011), with a high
incidence and mortality rates. On average, one Nigerian woman dies of cervical cancer
every hour (Federal Ministry of Health [FMoH], 2014). The age-standardized incidence
rate of cervical cancer is 34.5 per 100,000 (Ferlay et al., 2014). There is an upsurge in
invasive cases, as retrospective studies in three tertiary hospitals in three different regions
(Jos, Zaria, and Nnewi) of the country, found that more than 70% of the patients presented
with advanced stage cervical cancer (Ikechebelu, Onyiaorah, Ugboaja, Anyiam, & Eleje,
2010; Musa et al., 2016; Oguntayo et al., 2011).
Even with the reported high burden of cervical cancer in Nigeria, accurate
morbidity and mortality rates are unknown, due to gross underreporting, misdiagnosis,
suboptimal record keeping and improper data from poorly funded cancer registries. It is
predicted that there will be 19,440 new cervical cancer cases and 10,991 cervical cancer
deaths by 2025 in Nigeria (Ferlay et al., 2014). The risk of HPV infection and cervical
cancer can be significantly reduced by HPV vaccination, Pap smear, Visual Inspection with
Acetic Acid (VIA) and HPV test.
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Prevention
HPV Vaccine. HPV vaccines have fostered the hope of eradication of HPV
infection and cervical cancer. The two types of HPV vaccines, Gardasil™and Cervarix™
provide protection against HPV infection. Gardasil is a quadrivalent vaccine that protects
against HPV types 6, 11, 16, and 18, while Gardasil-9 is a nine-valent HPV vaccine that
protects against HPV types 6, 11, 16, 18, 31, 45, 52, and 58 (CDC, 2016). Cervarix is a
bivalent vaccine that gives protection against HPV types 16 and 18. The World Health
Organization (WHO) recommends HPV vaccines for boys and girls aged 9 through 26
(WHO, 2014), while Center for Disease Control and Prevention recommends HPV
vaccination for preteen girls and boys at age 11 or 12 years and teens and young adults who
did not start or finish the vaccine series until they are 27 years old for women and 22 years
old for men. Two doses of HPV vaccine at least six months apart was recommended for
11- to 12-year-olds, and a three doses series is recommended for teens and young adults
who start the vaccine later than ages 15 (CDC, 2016).
The 2015 HPV vaccination guidelines by the American College of Obstetricians
and Gynecologist Committee do not recommend testing for HPV DNA prior to vaccination
in any population group; recommend vaccination among individuals who test positive to
HPV DNA and do not recommend routine pregnancy testing before HPV vaccination.
However, the guidelines warn that HPV vaccine should not be taken in pregnancy. HPV
vaccination is recommended for women regardless of sexual activity status (Munoz, et al.
2010; Paavonen, et al. 2010); for individuals who did not receive the vaccine at an early
age, and for men and women with compromised immune systems (including people living
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with HIV/AIDS) through age 26, if they did not get fully vaccinated when they were
younger (CDC, 2014).
Cervical Cancer Screening. HPV vaccination is projected to reduce substantial
prevalence of specific HPV 16/18 infections, cervical abnormalities and invasive cervical
cancer, if population coverage is high above 70% (WHO, 2009). Once in a lifetime
screening, performed by women in their 30s or 40s could reduce the risk of cervical cancer
by 25-30% (WHO, 2014). The implementation of Pap smear, Visual Inspection with Acetic
Acid (VIA) and HPV screening is essential for detecting the HPV virus and early cell
changes on the cervix. Pap smear and VIA facilitates early detection and successful
treatment of precancerous cervical lesions. Pap smear is recommended for all women
between the ages of 21 and 65 years old (CDC, 2016). Women who are 30 years old or
older are encouraged to have an HPV test along with the Pap smear (CDC, 2016). The HPV
test is a “qualitative multiplex assay that simultaneously provides specific genotyping
information for HPV types 16 and 18, and a pooled result of 12 high risk strains of HPV
DNA’’ (Roche Molecular Inc., 2014, p.10). HPV tests eliminates the need for an initial
pelvic exam by providing women an opportunity to collect samples of their own vaginal
cells for testing (Arbyn et al, 2014). With normal pap test results, a woman is expected to
wait for three years before repeating another Pap test (CDC, 2017; Ronco et al., 2014).
With normal HPV test and Pap test results, a woman can wait as long as 5 years before
getting another screening test (Ronco et al., 2014), as her chances of getting cervical cancer
in the next few years is very low (CDC, 2017).
The World Health Organization (WHO), together with CDC and other health
organizations included visual inspection with acetic acid (VIA) and treatment with
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cryotherapy in the cervical cancer screening guidelines as screening methods for cervical
cancer in low-resource settings (WHO, 2013; CDC, 2015). VIA involves staining the
cervix with a 5% acetic acid (vinegar) solution, and an abnormal cervical tissue turns white
after 30 to 60 seconds. VIA has helped increase the detection of precancerous cells by
increasing screening coverage in some developing countries (WHO, 2012; Quentin et al.,
2011; Nessa et al., 2010; Zhang et al., 2010; Mwanahamuntu, et al., 2011; Mwanahamuntu,
et al., 2013). In Nigeria, the uptake of cervical cancer screening is extremely low, as fewer
than 10% of Nigerian women have ever had a cervical cancer screening (Idowu,
Olowookere, Fagbemi, & Ogunlaja, 2016; Wright, Aiyedehin, Akinyinka, & Ilozumba,
2014). Poor uptake of cervical cancer screening was documented even among health
providers in Lagos Nigeria, where 60% of the nurses reported never having been screened
for cervical cancer (Awodele et al., 2011).
Barriers
The low uptake of HPV vaccine and cervical cancer screening in Nigeria is
exacerbated by multiple personal, social, political and institutional factors. Reported
barriers include: lack of awareness of the vaccine; poor knowledge of disease and screening
techniques; erroneous perceptions, cultural beliefs and practices; fear of pain from the
procedure; fear of the outcome of the test; lack of decision making ability and spousal
support; stigma and modesty, the cost of screening, barrier to access, associated costs,
deficiencies within the health care system and health facilities (Ezenwa, Balogun, &
Okafor, 2013; Lim & Ojo, 2017; Modibbo, et al., 2016; Ndikom, Ofi & Omokhodion,
2014). Even among urban and educated Nigerian women, the level of awareness and
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knowledge of cervical cancer were found to be low (Hyacinth, Adekeye, Ibeh & Osoba,
2012).
With prevention and early detection, HPV infection and cervical cancer are largely
avoidable diseases. The incidence of HPV infection and cervical cancer are very high in
Nigeria due to poor uptake of cervical cancer screening measures and HPV vaccine.
Cervical cancer has a profound societal impact as it mainly affects women between the
ages of 30 to 50, who are often raising or supporting families (Goumbri, Domagni, Sanou,
Konsegre, & Soudre, 2009). Although cervical cancer affects only women, HPV affects
both men and women equally. A woman’s risk of contracting HPV infection and
subsequently developing cervical cancer does not depend on her sexual behavior alone, but
also on her male partner(s)’ sexual activities, as men are both vectors and carriers of HPV.
Lack of spousal support, stigma and modesty are social barriers that are beyond the control
of the woman and require the involvement of men.
The impact of sociocultural factors, including lack of spousal support, is widely
recognized as hindering the uptake of cervical cancer preventive measures (Ezeonwu,
2014; Modibbo et al., 2016). This is not surprising, given that Nigeria is a male-dominated
society where men are in charge of economies, are the sole family decision-makers, and
women are subservient to male family members (Ifemeje & Ogugua, 2012; Lim & Ojo,
2017). Only 15% of Nigerian women have a personal bank account (Council, 2012); only
one-third of currently married women participate in household decisions; only 40% of
married women participate in decisions about their own health and 50% do not participate
in any decisions made in the household (National Population Commission and ICF
International, 2014).
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Since the mid-1990s, the importance of involving men in reproductive health
programs has gained increasing recognition, along with attention to the sociocultural
factors affecting women’s reproductive health. The World Health Organization (2006)
recommended involving men in the prevention of cervical cancer in middle and lowincome countries. Studies conducted in developing countries have suggested that lack of
male involvement may be an overlooked obstacle to cervical cancer screening (Kim et al.,
2012; Lim & Ojo, 2017; Lyimo & Beran, 2012). Men play critical roles in women's abilities
to seek health care, yet, more often than not, they are uninformed about both their own and
women's reproductive health needs. Despite the role men play in their partners’
reproductive health experiences, HPV and cervical cancer programs in Nigeria have
focused only on women in reducing the incidence of HPV and cervical cancer; and little
attention has been devoted to the social factors that expose women to HPV infection, and/or
hinder them from taking the preventive measures.
As will be discussed in more detail in Chapter 3, prior research has shown that
increasing awareness and knowledge of HPV, HPV vaccination, and cervical cancer, and
cervical cancer screening has been effective in increasing both behavioral intention and
behavior (Wright, Kuyinu, & Faduyile, 2010; Ndikom, Ofi, Omokhodion, & Adedokun,
2017). The aim of this research was to implement an educational intervention, delivered
using two strategies: one that could be efficiently delivered to groups in natural settings
such as churches, and one that could be delivered to individuals who may not be accessible
in group settings in order to reach as many people in the target population as possible.
Members of the target population who are accessible and amenable to a community-based
group intervention versus a community-based individual intervention likely have

7

meaningfully different sociodemographic characteristics and, possibly, differing baseline
knowledge and beliefs about HPV, cervical cancer, and the associated risk reduction
methods. Thus, the overall purpose of this study is to establish the feasibility of delivering
group and individual interventions to the target population, and to test the independent
outcomes of each intervention rather than on comparing the two interventions.
Study Aims and Research Questions
The primary aim of this research was to determine the effectiveness of a communitybased educational intervention delivered in groups or to individual men and women living
in an urban area of southeastern Nigeria. The goal was to increase knowledge of HPV
infection and cervical cancer, and intention to take and or encourage HPV vaccine and
screening. Specific research questions were:
For each community-based educational intervention strategy:
What is the level of knowledge of HPV and cervical cancer at post-test versus pretest?
What is the intention to take and or encourage HPV vaccine and cervical cancer
screening at post-test versus pre-test?
What is the stigma associated with HPV and cervical cancer at post-test versus pretest?
What variation in knowledge of HPV and cervical cancer were observed among
participants based on age, marital status and educational level at post-test versus
pre-test?
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Theoretical Framework: The Theory of Gender and Power (TGP) was selected to
guide the exploration of male participation in cervical cancer prevention and the need for
an educational intervention, considering the low awareness, poor knowledge and low
uptake of HPV vaccine and cervical cancer screening. In addition to TGP, the Precaution
Adoption Process Model guided the study.
TGP is a social structural theory that explore the depths of sexual inequity, gender
and power imbalance (Connell, 1987). Connell identified three major structures that
characterize the gendered relationships between men and women: the sexual division of
labor, the sexual division of power, and the structure of cathexis. The three major structures
are less evident in the institutional level but remain largely intact at the societal level over
a long period, even as society slowly changes.
The sexual division of labor refers to occupational differentiation by gender
(Connell, 1987). Nigerian women are generally assigned to lower paying jobs, positions
and salaries or relegated to non-income generating labor such as housework, taking care of
farmland, childrearing, and caring for the dependent member of the family. This type of
work does not have assigned economic wages, so women often earn nothing from doing
them. This makes them financially dependent, relying on men for all their needs; thus,
constraining women and limiting their economic potential and career paths. These genderdetermined roles and discriminatory practices relegate Nigerian women to domestic work,
unequal pay for comparable work, prescribed behaviors and expectations, and power
imbalance within relationships (Ifemeje & Ogugua, 2012).
The sexual division of power deals with the inequalities in power between men and
women. This structure at the household level is maintained by social practice, such as
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through the abuse of authority, control in relationships and marginalization of women
(Wingood & DiClemente, 2000). Nigerian culture reinforces women to see themselves as
the lesser gender, be more submissive and subordinate to the male gender (Nnadi, 2013).
The recent National Population Commission report revealed that only one-third of
currently married Nigerian women participate in household decisions, and nearly four in
ten married women participate in decisions about their own health care. Half of the married
women do not participate in any decisions made in their home (NPC & ICF International,
2014). Gender power inequality, especially in the form of relationship power imbalances,
plays a role in sexually transmitted infection (Smith, 2007).
The structure of cathexis, also referred to as the structure of social norms and
affective attachment, addresses the affective nature of relationships between men and
women. It dictates appropriate gender role, the sexual expectations and prescribed
behaviors of each gender at the societal level. This structure describes the constrained
expectations the society has for women regarding their sexuality, and consequently, shapes
their perceptions and limits their experiences of reality.
The prescribed cultural gender roles limit communication and shared decision
making among couples especially on sexually related matters (Dunkle et al., 2007). Sexual
related issues are deemed sensitive and are rarely discussed in most Nigerian communities,
which often affect communications in marriage, thus hindering women’s expression of self,
request of what they want and discussion of their reproductive health with their spouses.
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Male Involvement

Sexual division of power
Physical exposures
Partner disapproval of service
use
Male preference
Physical and sexual abuse
High risk steady partner
Older partner

Sexual division of labour
Socio-economic exposure
No/low finance
Un/underemployment
Low educational attainment
Early marriage
Few political/policy-making
positions

Women
vulnerability to
HPV infection and
cervical cancer

Structure of Cathexis
Social exposure
Conservative cultural and
gender norms
Low self-efficacy to take
action
Cultural/religious norm of
modesty
Limited expectations and
movements

Increased uptake of HPV vaccine and
Cervical cancer screenings

Figure 1.1: Proposed Modified Theory of Gender and Power
Methodological Model. The Precaution Adoption Process Model (PAPM)
explains how a person comes to decisions to take action and how he or she translates that
decision into action (Weinstein & Sandman, 1992). The adoption of a new behavior or
precaution or cessation of an unhealthy behavior requires deliberate steps unlikely to occur
outside of conscious awareness. The model identifies seven stages along the path from lack
of awareness to maintenance of action over time. Given that this research only focused on
11

knowledge and intention to take HPV vaccine and Pap smear, only the first five stages of
the PAPM apply. Figure 1.2 illustrates the application of the five stages of the Precaution
Adoption Process Model to this research, with the aim of increasing the knowledge of HPV
and cervical cancer, and intention to take HPV vaccine and cervical cancer screening.

Stage 1

Stage 2

Stage 3

Stage 5

Information
about HPV
infection,
Cervical cancer,
and their
preventive
measures

More attention on
the severity of the
diseases and the
benefit of the
preventive
measures

Contemplating
avoiding the
risk factors and
uptake of HPV
vaccine and
cervical cancer
screenings

Intention to take
or encourage
partner to take
HPV vaccine
and cervical
cancer
screenings

Stage 4
Intention to not
take or
encourage
partner to take
HPV vaccine
and cervical
cancer
screenings

Figure 1.2: Modified Precaution Adoption Process Model
Stage 1 represents the initial point in time when people become aware of HPV
infection and cervical cancer. Awareness is the first step to developing an attitude or belief
about an issue. Individuals who have never heard of HPV infection and cervical cancer,
cannot have formed opinions or beliefs about the disease or preventive measures. Creating
awareness on HPV and cervical cancer is vital in building knowledge. Stage 2 represents
the point at which individuals first receive information or learn about the HPV infection
and cervical cancer, although they are not yet engaged by this information. Being aware of
12

a disease or its preventive measures increases the possibility of developing an opinion
about them. However, people will think about an issue or develop an opinion depending
on the level of awareness or the quality of information known. In terms of this research,
the educational interventions are designed to both create awareness and provide
participants with information on HPV, cervical cancer, HPV vaccine and cervical cancer
screening. The aim is to encourage participants to think about both the disease and the
available preventive measures.
Providing adequate information stimulates thoughts about the issue, and people
begin to consider the issue and have an opinion about it, represented in Stage 3. It is quite
common for people to be aware of an issue without being personally engaged with the
issue. When they become engaged, they begin to think of assuming a position.
Furthermore, people who have a definite position on an issue decide either to take or not
to take action. The outcomes of Stage 3 (decision making time) will vary depending on
individual differences. Some people may suspend judgment and remain in stage 3 for some
time. Others may decide not to take action (Stage 4). Deciding not to take action means
halting the precaution adoption process at least for the time being. Deciding to take action
by adopting the precaution is represented in Stage 5. Whichever position an individual
assumes results in overconfidence in one’s beliefs; searches for evidence to favor one’s
beliefs, interpretations of data to favor beliefs; and insufficient adjustment of beliefs in
light of new evidence (Klayman, 1995). One factor that influences people’s decision
regarding HPV vaccination is perceived susceptibility (Connor & Norman, 1995). The aim
of the educational interventions was to enhance participants’ recognition of their or their
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family members’ susceptibility to HPV infection and cervical cancer risk. The following
chapter contains the research plan.
Overview of Manuscripts and Target Journals
This dissertation is organized in the manuscript format. The aim of this research
was to assess if a community-based educational intervention delivered to men and women
living in an urban area of Nigeria would increase the knowledge of HPV infection and
cervical cancer, increase intention to take HPV vaccine and screening, and reduce stigma
about HPV infection and cervical cancer. The community-based health education
intervention included participants who received a face-to-face presentation on HPV
infection, cervical cancer, HPV vaccination and cervical cancer screening (Presentation
Group) and individual participants who read a pamphlet containing similar information
(Pamphlet Group). A total of 281 men and women between the age of 18 and 65 years who
could- read and write in English and resided in Anambra state participated in the study.
The survey instrument, a self-administered survey, was given to the participants before and
after the intervention.
Data analysis consisting of descriptive statistics (frequency and percentage)
inferential statistics (T-test, Chi-square and logistic regression) were done using Statistical
Analysis System (SAS) software. This study is significant in many ways and has
importance to diverse audiences. The findings from this study may assist governments and
Non-governmental organizations in planning interventions to increase HPV vaccination
and cervical cancer screening in Nigeria. In addition, program planners and researchers
may build on the findings or use the findings to guide future research on HPV and cervical
cancer.
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The first manuscript is a scoping review of male participation in reproductive health
interventions in sub-Sahara Africa. The manuscript emphasizes men’s shared
responsibility and active involvement in sexual and reproductive behavior as an important
step in improving reproductive and maternal health. The review synthesis examined and
describes the outcome of men’s participation in various reproductive health programs such
as family planning, birth preparedness, dual protection from HIV/sexually transmitted
infections (STI), and maternal health service utilization carried out between 2007 and 2018
in Sub-Sahara Africa. This manuscript has been submitted to the International Perspective
on Sexual and Reproductive Health Journal.
The next two manuscripts describe the effectiveness of the community-based health
education intervention in improving knowledge of HPV and cervical cancer, increasing
intention to take HPV vaccine and cervical screening and reducing HPV and cervical
cancer stigma among men and women in Nigeria. The first manuscript details the changes
in awareness, knowledge and intention to take to HPV vaccination and cervical cancer
screening before and after the educational intervention. (Chapter 3). The manuscript will
be submitted to the International Journal of Public Health. The second manuscript describes
an evaluation of educational intervention to reduce stigma associated HPV and Cervical
cancer in Nigeria. The target journal for this manuscript is the Global Public Health
Journal.
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CHAPTER 2
MALE PARTICIPATION IN REPRODUCTIVE HEALTH INTERVENTIONS IN
SUB-SAHARAN AFRICA: A SCOPING REVIEW
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Background
Over the past two decades, there has been only minimal improvement in women’s
reproductive health indicators in the African region (WHO, 2014). Reproductive and
sexual health problems represent one-third of the total global burden of disease for women
between the ages of 15 and 44 (WHO, 2013). Maternal mortality rates in the region are
among the highest in the world, with nearly half of the estimated 830 daily maternal deaths
occurring in sub-Saharan (Alkema et al., 2016). Hypertension during pregnancy (e.g., preeclampsia and eclampsia), complications from delivery, unsafe/unattended abortion, and
postpartum hemorrhage and infections account for nearly 73% of all maternal deaths
worldwide (Say et al., 2014). Over the past 20 years, the maternal mortality rate in Africa
has declined only 2.7%, yet the maternal mortality rate needs to continue to decline at least
5.5% per year in order to reach the Millennium Development Goal 5 of universal access to
reproductive health with a 75% reduction in the maternal mortality rate and in the African
region (WHO, United Nations Department of Public Information [UNICEF], United
Nations Children's Fund [UNFPA], The World Bank, 2012). Given that between 1990 and
2010 the total rate of decline was only 2.7%, it is clear that persistent challenges to
improved maternal health are not being adequately addressed.
Persistent gender, social and ethnic disparities continue to inhibit progress in
women’s health across the globe (International Conference on Population and
Development [ICPD], 2014). In Sub-Sahara Africa, gendered cultural beliefs and practices,
and limited access, affordability, and utilization of health facilities contribute to women’s
health disparities. Culturally, men are the decision makers and gatekeepers in most African
families and therefore hold power and influence over decisions regarding women’s access
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to health services, contraception and prevention of sexually transmitted infections (STI).
Furthermore, men often control the allocation of money, transportation, time and
permission women need to access health services.
The importance of involving men in reproductive health programs has gained
increasing recognition since the mid-1990s, and there is increasing recognition that men’s
participation in reproductive and sexual health is an important step in supporting women’s
health and improving family health. Formally recognized at the 1994 International
Conference on Population and Development, at the 1995 Women's International
Conference in Beijing, three avenues for men’s active inclusion and shared responsibility
in women’s health were identified: (1) promoting men’s use of contraceptives through
increased education and distribution; (2) involving men in roles supportive of women’s
sexual and reproductive decisions; and (3) encouraging men to indulge in responsible
sexual and reproductive practices to prevent and control STIs (United Nations Department
of Public Information, 1995; UNFPA, 2004).
Researchers have explored the importance of men’s involvement in women’s
decision-making and use of reproductive health services in Sub-Sahara Africa in various
studies using a wide range of research designs and methods. An assessment of women’s
sex preference, decision making and fertility control in the Ekpoma community in south
southern Nigeria showed that more than half of the women believed it is the man’s right to
make the final decisions in the home including reproductive decisions (Agatha, Sims, &
Godfrey, 2007). Similarly, an examination of the motivations and preferences of rural
Nigerian women undergoing cervical cancer screening indicated the most frequently
reported motivating factors of women’s participation in cervical cancer screening were the
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support and opinion of her husband and the community leaders (Chigbu, Onyebuchi, Ajah,
& Onwudiwe, 2013). Not surprising, in studies conducted in both Burkina Faso Sawadogo,
Gitta, Rutebemberwa, Sawadogo, & Meda, 2014) and Nigeria (Ezeonwu, 2014; Modibbo,
2016), lack of spousal support was identified as one of the reasons for women not being
screened for cervical cancer.
Recognizing the sociocultural factors exposing women to a higher risk of
contracting sexual transmitted infections, the Joint United Nations Programme on
HIV/AIDS (UNAIDS, 2010) called for development and implementation of innovative
strategies to further educate men about women’s health. To further strengthen and promote
the recommendation of male involvement in reproductive health interventions, it is
imperative to examine the impact of male involvement in reproductive health interventions
(family planning, sexual risk behaviors, antenatal care, birth preparedness, maternal
health). Reproductive health program planners and researchers have employed various
interventions involving men in an effort to improve reproductive health and increase the
utilization of reproductive health services. Examples include invitation letters, home visits,
community events and use of community health workers. The previously published
reviews on male participation in women’s health issues in Sub-Sahara Africa focus on
prevention of mother-to-child transmission of HIV, HIV counselling and testing, HIV
reduction barriers and facilitators as opposed to interventions to improve reproductive
health (Auvinen, Kylma, & Suominen, 2013; Burton, Darbes, & Operario, 2010; Hensen,
Taoka, Lewis, Weiss, & Hargreaves, 2014; Morfaw, et al., 2013). The specific aim of this
scoping review was to examine evidence published between 2007 and 2018 related to
evaluation of reproductive health interventions that involved men in efforts to improve
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reproductive and maternal health in Sub-Sahara Africa from 2007 to 2018. This review is
of interest to health care providers, researchers and public health planners concerned with
reproductive health issues, particularly among women in Sub-Saharan Africa, but also in
other regions of the globe.
Methods
We conducted multiple searches through Google Scholar, PubMed, Science Direct,
Medline, Global Health, PsycInfo and Cumulative Index to Nursing and Allied Health
Literature. Search terms were related to male involvement (i.e., male, men, spouse, couple,
involvement, participation, engagement, program, trials, spouse; couple) in reproductive
health issues (i.e., family planning, sexual risk behaviors, antenatal care, birth
preparedness, maternal health, reproductive health, maternal health, sexual health; family
planning; antenatal care, condom use, birth preparedness) in Sub-Sahara Africa (i.e.,
Nigeria, Malawi, Ethiopia, Tanzania). Once retrieved, articles were further screened using
the following inclusion criteria: (1) articles published in English between January 2007 and
March 2018; (2) reports of reproductive health interventions involving men in Sub-Saharan
Africa; and (4) reports of research that employed an experimental or quasi-experimental
study design. Subsequent to the identification of relevant sources, the reference list of each
identified article was reviewed to identify additional eligible studies (three articles were
included). Excluded were reports of programs that only addressed prevention of motherto-child transmission of HIV and HIV counselling and testing.
The initial electronic bibliographic search yielded titles of 2,847 articles, including
1,313 duplicates which were subsequently excluded. An examination of the titles of the
remaining 1,534 articles resulted in further exclusion of 1,275, yielding a sample of 259
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research reports that met the inclusion criteria for full-text review. Of these, 18 articles met
the criteria and were submitted to independent review by a second independent examiner,
who independently examined all 18 full texts and confirmed all manuscripts met the
inclusion criteria. Subsequently, the following information from each study was entered
into a Microsoft Excel database: title, authors, publication date, intervention-publication
interval, sample characteristics, location, study design, type of reproductive and/or
maternal health program, data collection method(s), comparison group, outcome measures,
intervention characteristics (i.e., number and types of intervention strategies, outcome
measures), and intervention strategies (i.e., individual or couple-based approaches). One
person extracted, and both reviewed; and reviewers discussed any disagreements in the
data extracted.
Results
The final sample consisted of 18 interventions articles were published between
2007 and 2018, each of which included an evaluation of men’s involvement in a
reproductive health intervention in Sub-Saharan Africa. The articles included research
conducted in Nigeria (n=6), Malawi (n=5), Tanzania (n=3), Uganda (n=2), Ethiopia (n=1),
Senegal (n=1), Kenya (n=1) and Mozambique (n=1). Couples, men living with female
partners, and men only were the most common target group (17); one study involved only
women with information focused on men and encouraged women to deliver the
information. The majority of the participants were 18 years of age and above, although six
studies included participants as young as 14 and 15 years. The reproductive health outcome
measures were family planning (n=9), maternal health/service utilization (n=8), HIV
counselling and testing (n=4), birth preparedness (n=1), dual protection from HIV/STI

21

(n=1) and uptake and adherence of antiretroviral therapy (n=1). The research designs
included surveys, interviews and focus groups. Five studies included a theory-based
intervention to assess impact of male involvement in reproductive health (Adeleye &
Okonkwo, 2016; Adeleye, Aldoory, & Parakoyi, 2011; Exner et al., 2009; and Hartmann
et al., 2012; Shattuck, et al., 2011). Overall, the study designs reported in the articles were
12 quantitative, 1 qualitative, and 5 mixed methods studies.
Intervention Theoretical Framework and Design
The most common theoretical frameworks were Gender Theory and the
Information-Motivation-Behavioral Skills Model. Adeleye & Okonkwo, (2016) and
Adeleye, Aldoory, & Parakoyi, (2011) employed the Gender Theory to explore maternal
health services utilization. Gender Theory posits that gender constitutes the social,
economic, and political contexts that guide particular beliefs, norms, and behaviors. In their
research conducted in Malawi, Shattuck, et al., (2011) and Hartmann et al., (2012)
employed the Information-Motivation-Behavioral skills model which postulates that
health-related information, motivation, and behavioral skills are important determinants of
whether a family planning behavior is performed. Exner et al., (2009) used the Stages of
Change Model to guide the intervention to promote dual protection against HIV/STI.
In terms of research design, there were three randomized controlled trials (RCTs),
eleven studies that employed a pretest/posttest design and four studies that were posttestonly. Furthermore, eight studies had a comparison group and fifteen studies used at least
three intervention strategies. In this review, 10 studies were couple-based interventions,
seven studies targeted only men and one study targeted only women. The couple-based
interventions were focused on family planning, HIV counselling and testing and maternal
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health services utilization. The studies that targeted only men explored HIV/STI dual
protection, maternal health services utilization, birth preparedness and family planning.
Interestingly, one study had only women as the study participants, and the purpose was to
assess the women’s perspectives about the impact a maternal health mass media campaign
had on their husbands. Almost all the studies assessed the impact of male involvement in
marriage relationships and/or co-habiting relationships. Nine studies were conducted in
urban settings, eight studies were conducted in rural settings and one study involved
participants residing in both urban and rural settings.
Intervention Content and Outcomes
Uptake of family planning services was the primary outcome measure in the
majority of the studies (n=9), followed by maternal health service utilization (n=6).
Collectively, these studies indicated that inclusion of men in reproductive health
interventions is an essential component of effective reproductive health interventions in
Sub-Saharan African.
Men’s Willingness to Participate
Studies conducted in Nigeria, Ethiopia, and Uganda evaluated men’s willingness
to participate and complete the reproductive health programs. The reports indicated high
participation and retention among their participants. The use of local culture and gender
roles to improve men’s involvement in maternal health, Adeleye, Aldoory, and Parakoyi,
(2011) reported that about 90% of the participants attended nine group health talks which
averaged 2 hours in duration and were conducted over in 4-week period in Nigeria. In
similar study in Nigeria, more than 90% of the respondents had attended a two-hour
educational session on maternal death (Adeleye, Aldoory, & Parakoyi, 2011). Exner and
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colleagues (2009) observed that the majority (91 %) of the men who participated in a
program to increase dual protection against HIV/STI attended two five-hour sessions
scheduled one week apart, and 75% attended both monthly two-hour ‘check-in’ sessions
post-intervention (Exner et al., 2009).
Furthermore, among couples who participated in a family planning intervention
aimed at encouraging spousal communication, 92% of the couples responded to face-toface discussions (Tilahun, Coene, Temmerman, & Degomme, 2015). Similarly,
Ghanotakis and colleagues (2016) reported 65% of male participants attended all 10
sessions focused on transforming gender norms and encouraging uptake of family planning
and HIV services. Interestingly, nearly all participants reported complete trust in the
credibility of the information shared and high satisfaction with the workshop. These
findings challenge the conventional assumptions and stereotypical perceptions that most
African men are not interested in participating in programs involving women’s health and
healthcare services (Chipeta, Chimwaza, & Kalilani-Phiri, 2010; Olawoye et al., 2005).
These findings clearly suggest African men are willing to participate in reproductive health
programs, either individually or with their partner/spouse and provide further support for
the notion that providers, researchers and program planners should be attentive and actively
respond to opportunities to include men in reproductive health programs and services.
Couple-Oriented Interventions
There were ten examples of reproductive health interventions designed for married
or co-habituating partners. The focus of these interventions was either family planning
uptake (Hartmann, Gilles, Shattuck, Kerner, & Guest, 2012; Shattuck, et al., 2011; Tilahun,
Coene, Temmerman, & Degomme, 2015; Becker, et al., 2014; Lemani, et al., 2017) or
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maternal health (i.e., obstetric care, antenatal care, skilled birth attendance) alone or with
HIV counselling and testing and or gender norm transformation (Jefferys, et al., 2015;
Byamugisha, et al., 2011; Bright, et al., 2015; August, Pembe, Mpembeni, Axemo, & Darj,
2016; Mushi, Mpembeni, & Jahn, 2010). Intervention contents namely, education,
counseling, behavioral skills, home visits, follow-up visits and community events were all
efficacious strategies that resulted in positive outcomes.
Further, community-engaged and collaborative approaches such as communitybased participatory research (CBPR) were defining characteristics of these programs to
generate meaningful outcomes. Trained community health workers (CHWs) were used in
six studies, to provide the community interventions (Hartmann, Gilles, Shattuck, Kerner,
& Guest, 2012; Becker, et al., 2014; Lemani, et al., 2017; August, Pembe, Mpembeni,
Axemo, & Darj, 2016; Mushi, Mpembeni, & Jahn, 2010; Audet, et al., 2016). In these
instances, CHWs were members of the local community, without formal professional
health training. They were referred to by a variety of terms, including promoters,
traditional birth attendants, male champions, community health counselors, community
agents, lay providers, and peer support specialists. For example, August and colleagues
employed and trained trusted men and women who had completed primary school and
could read and write in the villages to identify pregnant women in the community and make
at least four visits to the family throughout the pregnancy (August et al, 2016). Similarly,
health surveillance assistants, stratified by sex and catchment area, visited women from
their catchment areas in their homes and counseled them on family planning alone and with
the male partner. The Health Surveillance Assistants (HSA) would then initiate the family
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planning method of the woman’s choice if the woman asked for a short-term method or
refer her to the nearest facility for long-term family planning methods (Lemani et al, 2017)
Utilization of community-based approaches to health promotion and prevention
may reduce the challenges of standard research approaches, strengthen the rigor and utility
of science for community applicability, enhance evidence-based translation to local
communities, and demonstrate both individual and community benefit (Horowitz,
Robinson, & Seifer, 2009). For example, Audet and colleagues (2016) conducted a
community participatory action program in Mozambique that integrated and deployed
CHWs to the community to engage men in prenatal care services and increase HIV testing
and treatment uptake. The CHWs established a male-friendly clinical environment and
provided couples counseling sessions. The CHW intervention increased male
accompaniment at antenatal care appointments, HIV testing among pregnant woman, male
partner presence at antenatal visits, maternal attendance at a minimum of three antenatal
appointments, and slight decreased median gestational age at first antenatal care visit.
Partner accompaniment to antenatal care was associated with higher odds of health facility
delivery, but little difference in odds of anti-retroviral treatment initiation (Audet et al.,
2016).
Benefits of CHW engagement include their familiarity with local issues, existing
rapport with community members, and circumvent the problem of a scarcity of other
human resources. Becker and colleagues (2014) reported on the utilization of a pair of
CHWs in Malawi to provide family planning and or HIV counseling and testing in a single
home visit to couples. They reported that more than 75% of the women and men visited by
CHWs subsequently received their first HIV test and about 60% of couples tested
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subsequently reported they discussed the results of their HIV test as a couple. The results
also indicated a significant increase in condom use during the most recent sexual
intercourse, and there were no reported incidents of serious violence among any of the
couples at the one-week follow-up visit. In a similar study in Malawi, women who received
couples counseling training were more likely to have their partners present during
subsequent counseling and to receive condoms at their first family planning visit (Lemani
et al., 2017).
Other reported outcomes of CHW interventions include improved community
perception, acceptability and utilization of obstetric care among couples (Mushi et al.
2010). Mushi and colleagues used community-based safe motherhood promoters to
improve the utilization of obstetric care in a rural district of Tanzania. Findings included a
significant increase in early antenatal booking by primigravida mothers, in the number or
primigravida women attending at least one antenatal visits and in the proportion of women
who delivered with skilled attendants. In addition to antenatal care attendance at least once
during pregnancy by all the women, the number of respondents who were able to mention
at least three pregnancy risk factors and cite at least three practices that contribute to delay
in seeking obstetric care increased signficantly (Mushi et al. 2010). In Tanzania, CHWs
delivered a Home-Based Life Saving Skills training for pregnant women. The CHWs made
a minimum of four visits to the family during the period of the woman’s pregnancy.
Women who received the CHW visits had increased levels of knowledge of potential
danger signs during pregnancy, childbirth, and postpartum. Also, a higher proportion of
men accompanied their partner/wives to prenatal care visits and a higher proportion of

27

women were involved in shared decision-making about place of delivery (August et al.,
2016).
Given that CHWs are trained to provide the culturally and context‐specific
advocacy and engage in the reciprocal exchange of information within familial social
contexts, these findings are not surprising. CHWs serve as vital links, bridges, and in‐
between people, brokering between the world in which they and their neighbors live and
the healthcare system (Norris et al., 2006). Similar results were reported in CHW-delivered
family planning intervention studies in Malawi and in Ethiopia. A Randomized Controlled
Trial on couples’ family planning communication in Malawi used five visits to provide
information, motivation, and behavioral skills to intervention group particpants. The
intervention was delivered by a male motivator over 6 months. As compared to the control
group, intervention group participants reported a significant increase in contraceptive use,
in ease and frequency of discussing family planning with their partners, the use of joint
process for deciding to use family planning, and reduced differential couple
communication (Hartmann et al., 2012). The authors added that the frequency with which
men discussed family planning with their wives was a significant predictor of family
planning uptake. Tilahun and colleagues (2015) measured spousal communication and
family planning uptake among couples in Ethiopia. They reported a positive association
between the intervention and use of contraception among those who were not using
contraceptives at baseline, and higher levels of husbands’ involvement and spousal
discussion on family planning. However, no significant difference in contraceptive use was
found between the intervention and control arms. These findings provide further evidence
that CHWs programs may be more successful in community‐based, participatory models,
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in which community members and healthcare and other agencies have shared values,
equity, planning and participation (Norris et al., 2006).
In all ten of these studies, regardless of the type of reproductive health program,
intervention strategy, or duration of intervention, male involvement in couples-orientated
programs was efficacious. Three studies employed formal written invitation letters to
incentivize male participation in women’s reproductive health (Jeffreys et al., 2015;
Byamugisha1 et al., 2011; Bright et al., 2011). In Tanzania, Jeffreys and colleagues (2015)
used written invitations to motivate male partners to attend joint antenatal care and couple
voluntary counselling and testing. They reported 81% of the couples that attended a joint
antenatal care session received voluntary couple counselling and testing, and 71% reported
an improved relationship between with their partner. Beyond improved couple
communication and support, 96% of the women noted improved decision-making
regarding antenatal care, family planning and sexual and reproductive health (Jeffreys et
al, 2015).
Similarly, in Uganda, Byamugisha and colleagues (2011) reported the positive
effect of written invitation letter on couple antenatal attendance and partner acceptance of
HIV testing. More than 90% of males who attended the antenatal clinic visit with their
wives accepted HIV counselling and testing. Similarly, in Nigeria, male partners of
antenatal attendees who accepted an invitation to be part of a three-day participatory
training on female reproductive health and family planning showed a remarkable increase
(90%) in knowledge of methods of contraception and a higher proportion of men who
expressed intent to use family planning in the future. At follow-up with 50 couples, all
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male participants reported improved spousal communication on family planning (Bright et
al., 2015).
Interventions designed for men-only
There were seven examples of interventions delivered exclusively to men, without
the presence of partners or spouses (Adeleye, Aldoory & Parakoyi, 2011; Exner et al.,
2009; Ghanotakis et al., 2016; Shattuck et al., 2011; Adeleye & Okonkwo, 2016; Okigbo,
Speizer, Corroon, & Gueye, 2015). The content of these programs included family
planning, birth preparedness, dual protection from HIV/STI, and maternal health
improvement. Assessment of these interventions examined the level of men’s participation,
their adoption of the specific intervention, and level of spousal influence on the adoption
of the intervention by their wives. Various approaches to engage men were employed,
including peer-delivered interventions, male-friendly clinics, and active engagement of
community leaders. There is increasing recognition of the power and influence of peer
education in health promotion and illness prevention.
Peer-delivered educational interventions are important to involve and engage men
in reproductive health initiatives given the complex nature of relationships and societal
pressures. The reported peer-led interventions resulted in greater positive changes in
contraceptive uptake, and HIV service uptake. For example, post-assessment of a peerdelivered educational intervention designed to encourage contraceptive use among
Malawian men and to foster communication about family planning with their partners,
demonstrated a significant increase (78%) in male intent to use family-planning methods
among men in the intervention arm compared to 59% in the of the comparison arm.
Additionally, a significant increase using family-planning methods with their wife and
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intended to continue for 2 years; and overall communication about family planning with
their partner (Shattuck et al, 2011).
Similarly, in Uganda, peer educators delivered a community-based intervention to
improve family planning, HIV service uptake, and transform harmful gender norms
(Ghanotakis et al., 2016). Men who received the intervention reported higher levels of
seeking clinic services for self, condom use with main partners over the past three months,
having an HIV test, communicating with main partners on family planning method, and
accompanying a partner to the clinic in the past five months (Ghanotakis et al., 2016).
Given the wide recognition of peer education as an approach in communicating behavioral
changes especially in addressing HIV pandemic, these findings are not surprising (Harris,
Smith & Myer, 2000). Furthermore, health education and outreach by peers, community
health workers, and local community and religious leaders are cost-effective community
health promotion strategies that utilize local human resources.
Community and religious leaders are vital community members in Sub-Sahara
Africa, where collectivism is a way of living and community leaders’ opinions are an
important factor in women’s utilization of health services (Chigbu, et al., 2013). These
leaders are key stakeholders who can effect changes through advocacy, effective
mentorship, policy change, and seeking the support of benevolent community members
and organizations to improve community resources. Male community leaders in Nigeria
were motivated to act as change agents and encouraged other men to assist with maternal
health in their community after being engaged in group health talks to improve maternal
health (Adeleye, Aldoory, & Parakoyi, 2011). Okigbo and colleagues (2015) reported
similar findings in their assessment of a family planning program that was positively
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associated with men reporting increased use of modern contraception in Kenya, Nigeria
and Senegal. The program involved religious leaders in television programs, print media,
and community events aimed at increasing men’s exposure to family planning messages
and modern contraceptive use.
Furthermore, Nigerian men who had female partners were mobilized to increase
dual protection against HIV/STI, which produced notable outcomes. The participants were
one-third less likely to engage in unprotected sex in the prior 3 months, approximately four
times more likely to report condom use at last sexual intercourse with their main partner,
and approximately seven times more likely to correctly identifying venues for HIV testing.
Additional outcomes included: men’s partners were 10 times more likely to have been
tested for HIV/STI, the men had lower expectations that condoms would be associated with
a negative response in the context of their primary relationship, and the men held
significantly less stigmatized beliefs about HIV-infected people (Exner et al., 2009).
Male engagement in healthy sexual behaviors is essential to ensure the sexual and
reproductive health of women, girls, and families. Men are increasingly encouraged to
participate in improving maternal health because of their role as family gatekeepers. An
educational session on maternal deaths among married men in Nigeria showed large
improvement in their knowledge of family planning methods for females, facilities for
antenatal care and delivery, and key warning signs of maternal death (Adeleye &
Okonkwo, 2016). Additionally, there was increased willingness to provide money and
encourage partners to seek care. One of the key strategies to reduce maternal death and
increase safe motherhood is birth preparedness (Acharya, Kaur, Prasuna, & Rasheed,
2015). Birth preparedness includes knowing danger signs, planning for a birth attendant
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and birth location, arranging transportation, identifying a blood donor, and saving money
in case of an obstetric complication (Acharya, Kaur, Prasuna, & Rasheed, 2015). Although,
Ibrahim et al., (2014) reported that a behavioral intervention had no statistically significant
impact in the levels of birth preparedness among married men in Nigeria, they did observe
other positive behavioral changes among husbands who participated. These behavioral
changes included: encouraging their wives to attend antenatal clinic, accompanying their
wives to the clinic, reducing their wives’ household chores, taking care of their wives’
basic needs, granting their wives permission to seek health care when ill, taking their wives
to the health facility when ill, donating blood when it was needed, and regularly providing
traditional medicine for their wives (Ibrahim et al., 2014).
It is important to note that one way to reach men is to provide strong encouragement
for women to share key health messages and information with their partners. Indirect
involvement of men may be a way to enhance maternal health in Africa. For example,
Zamawe, Banda, and Dube (2015) assessed the impact of a maternal health mass media
campaign aired in Malawi and found a significant relationship between women’s exposure
to the radio campaign and an increased likelihood that their husbands were involved in
maternal health issues, including participating in antenatal care, being involved in
childbirth and participating in postnatal care.
Discussion
This review presents the current state of the science related to male involvement
in reproductive health interventions in Sub-Saharan Africa from 2007 to 2018. The salient
findings indicated male involvement is a feasible and effective strategy for improving
family planning usage, utilizing maternal health services, participating in HIV counselling
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and testing, changing some harmful gender-based norms, and reducing risky sexual
behaviors. There is clear evidence from the existing research that male community and
religious leaders are willing to be advocates and change agents and involved in women’s
health issues. Therefore, it is important that reproductive health programs are adapted to
and organized in line with the community local culture to enhance acceptance, adoption
and utilization. In most Sub-Saharan nations, individuals are strongly engrained in social
and cultural practices, norms, and expectations, which limits control and freedom for selfexpression, requiring submissiveness, especially from women and girls. This gender power
inequality plays a role in sexual and reproductive health.
The findings from this review showed that men are willing to participate in
reproductive health programs, which contradicts the stereotypically assumptions and
perception that African men are often uninterested in reproductive health and that
reproductive health responsibilities are solely the role of a woman (Chipeta, Chimwaza &
Kalilani-Phiri, 2010). Men are important partners in reproductive health, considering the
increasing emphasis on social determinants of health. The socio-cultural factors, especially
in relation to gender inequality, in developing countries makes this review very vital for
health providers, program planners and health organizations to be actively engaged in
creating and sustaining initiatives to include men in women’s health promotion. Based on
the literature analyzed, increased and enhanced male participation will support women’s
health choices and encourage shared decision making.
This analysis showed that irrespective of the duration of intervention, involving
men in various reproductive health programs is an important strategy in improving family
planning knowledge and uptake, HIV knowledge, counselling and testing, maternal health
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services use, spousal communication. In addition, involving men in reproductive health
programs reduced risky sexual behaviors and lessened their beliefs and reported behaviors
some harmful gender-based norms. The increased positive outcomes observed in this
analysis may be due to increased willingness and participation among the participants
which potential explains the improved retention of key messages, increased acquisition of
behavioral skills, increased communication among partners/couples and increased men’s
accompaniment. Increased knowledge about sexual health is associated with attitude
changes, which have been shown to influence behavior and practice (Davidson et al. 1985).
These findings corroborate others’ reports that providing men with information on healthy
maternal and reproductive health practices may encourage both the men and women to
adopt the behaviors, increase use of services, and support partners’ choices (Onyango,
Owoko, & Oguttu, 2010; Steinfeld et al., 2013; Wambui, Ek, & Alehagen, 2009).
Furthermore, there is clear evidence that the mobilization of men as partners in
reproductive health is very vital in reducing the spread of sexually transmitted infections.
Men who participated in the HIV/STI interventions were more likely to have higher safe
sex self-efficacy, use condoms and be tested for HIV/STIs. This review is especially
pertinent in Sub-Saharan Africa, where evidence suggests that many women are
contracting STIs such as HIV within the context of their primary relationships (Hirsch, et
al., 2007). The observed changes could be due to increased knowledge of the risk of unsafe
sexual practices on men and their partners and changes in attitude. The degree to which
these male participation interventions improved reproductive health depended on many
factors such as the number and type(s) of interventions implemented, the implementation
strategies, the quality of implementation, the type of outcome indicator(s) and the outcome
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measures. As observed in this review, increased contact is very important in increasing the
effectiveness of reproductive health interventions as almost all the studies had at least three
contacts with the participants, which were mostly the initial contact, continuing visits and
follow up contact. This is in line with the recommendation by WHO (2003).
This review highlights the fact that male involvement can be enhanced through
home-based intervention delivery, friendly facility-based service delivery, and engagement
with trained CHWs. It is well known that CHW engagement and the provision of homebased services are effective strategies to expand coverage and increase accessibility and
availability of services to people living in resource–constrained areas (Mushi et al., 2010;
Audet et al., 2016). These approaches are necessary in Sub-Sahara Africa, where a large
proportion of the low-income populations live more than one hour away from a health
facility (Pearson & Shoo, 2005). This finding corroborates other studies that used trained
CHWs to improve maternal health outcomes (Homer et al., 2014; Lane & Garrod, 2016).
It is important to note that findings from this review suggest that men’s involvement
may not significantly impact certain indicators of reproductive health interventions, such
as birth preparedness, and widespread gender-based norms (i.e., equal decision-making
power) in Sub-Saharan Africa. Interestingly, regardless of the lack of significant difference
with the primary outcome measures reported in few of the studies, there were positive
changes in other contributing factors like freedom to access care, increased spousal
communication and financial and emotional support. Several confounding factors may
inhibit the outcome of an intervention, which may not have been considered during the
planning phase. These include the type of marriage/relationship, educational levels,
financial capabilities of individuals, families, and communities, and religious beliefs. For
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example, a clear evidence of religious barriers to male involvement in birth preparedness
was observed by Ibrahim and colleagues (2014). In addition, polygamous marriages or
non-cohabiting relationships may contribute to limited success of birth preparedness as
men in these contexts may have competing needs or be less engaged with expectant
mothers. The lack of significant effects on birth preparedness may also be a consequence
of lack of spousal communication and lack of couples’ joint antenatal attendance, thus
resulting in limited exposure of men and women to the benefit of birth preparedness. These
findings suggest that others socio-demographic barriers must be considered when
involving men in interventions to promote birth preparedness.
This review corroborates other calls for the recognition of the importance of men’s
involvement in reproductive health, especially in developing nations. Given the evidence
that men’s involvement in reproductive health programs contributes to positive health and
social impacts, it is important to create and implement specific strategies aimed at
enhancing the involvement of both men and women in reproductive and family health
initiatives and in informing policy recommendations and programmatic planning to
improve reproductive health in Sub-Saharan Africa.
Limitations and Recommendations
To our knowledge, this is the first review to examine the effects of male partners
participation in reproductive health interventions in Sub-Sahara Africa and therefore is an
important contribution to the literature. These findings are limited to the available literature
accessible through major search engines within the past eleven years (2007 – 2018). Other
limitations include the exclusion of all literature published in languages other than English
and research that did not employ an experimental design. The decision to exclude non-
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experimental designs reflected the aim of exploring the impact of men’s engagement in
reproductive health issues. Thus, the review is restricted to an assessment of men’s
participation in reproductive health. Another potential limitation is that a single author
reviewed the individual papers for inclusion into the review.
These findings do provide the basis for several recommendation for future research
on male involvement in reproductive health in Africa and in developing nations. Further
research on male knowledge, attitudes, and involvement in reproductive health issues and
interventions within Sub-Sahara Africa clearly is warranted. Further research is needed to
support scale up of the best practices for involving men in further reproductive health.
Other area for further research include the assessment of specific mechanisms aimed at
enhancing male participation in reproductive health initiatives.
Conclusion
The evidence provided in this review clearly supports the recommendation that
involving men in reproductive health is essential to improving the health of women, men,
and families in Sub-Sahara Africa. There is clear evidence of the individual, family, and
community benefits of involving African men in reproductive health programs and
services. Involving men should not be limited to reproductive health programs and services
but also incorporated into efforts related to cervical cancer prevention, poverty alleviation,
and infant/child nutrition. Reproductive health programs should be gender comprehensive
and context-specific by bringing men to the table as equal partners rather than considering
their presence as a barrier. More research is warranted to support and strengthen the
findings of this review and to build evidence to support the sustainability and scaling-up
of male participation interventions in various health programs.
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CHAPTER 3
EFFECT OF A COMMUNITY-BASED EDUCATIONAL INTERVENTION ON
AWARENESS, KNOWLEDGE AND INTENTION TO TAKE HPV VACCINATION
AND CERVICAL CANCER SCREENING IN NIGERIA.
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Introduction
Worldwide, human papillomavirus (HPV) infection is the most common sexually
transmitted viral infection of the reproductive tract. HPV infection is so common that the
majority of sexually active men and women will be infected with at least one type of HPV
at some point and may have recurrent infections (Center for Disease Control [CDC], 2017).
Globally, the prevalence of HPV infection in women is 11–12%, with a much higher rate
of 24% in Sub-Saharan Africa (Forman, et al., 2012). At least 20% of women with normal
cervical cytology in Sub-Saharan Africa are infected with carcinogenic HPV genotypes
(De Vuyst et al., 2013). Nigeria is among the Sub-Saharan nations with high rates of HPVrelated diseases (Bruni, et al., 2018). Although there are currently no specific estimates of
HPV prevalence among the general population in Nigeria, available data from various
studies conducted in different cities and states indicate a high prevalence of HPV among
women. For example, a seroprevalence of 42.9% for IgG antibodies to HPV was reported
among women attending the reproductive health clinic in Zaria, a city in the northern
region (Aminu et al., 2014). Other researchers reported HPV infection rates of 30.4% and
36.5% among women who attended the outpatient clinics of a university teaching hospital
in Lagos, South-West Nigeria (Adegbesan-Omilabu, 2014; Okunade, et al., 2017).
Clinical challenges to identifying and tracking HPV infection include the fact that
it is difficult to detect the point at which an individual first became infected with HPV due
to the fact that the infection is asymptomatic, and symptoms often only develop many years
following initial infection (CDC, 2017). Although most HPV infections will clear without
medical intervention, individuals who contract persistent high-risk HPV types may
eventually develop cancer (CDC, 2017). Cervical cancer is by far the most common HPV-
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related cancer, as nearly all cases of cervical cancer can be attributable to HPV infection
(CDC, 2017). Cervical cancer is the second most common cancer among women in
Nigeria (Ferlay et al., 2014). Cervical cancer morbidity and mortality is high in Nigeria,
where an estimated 14,000 women are diagnosed annually with cervical cancer, and an
estimated 26 women die every day of cervical cancer (Ogundipe, 2013). The reported agespecific rate of cervical cancer in three states (Ibadan, Abuja, Calabar) were 36.0, 30.3, and
21.0/100,000 among women 15 years of age and above; (Jedy-Agba, et al., 2012; Ekanem,
et al., 2016). It is evident that cervical cancer is a disease affecting many women who may
still be giving birth, raising children and supporting the family financially.
HPV vaccines is projected to eliminate approximately 70% of cervical cancers and
once-in-a-lifetime screening, performed by women in their 30s or 40s could reduce the risk
of cervical cancer by 25 to 30% (WHO, 2014). Although the widespread availability and
uptake of HPV vaccine and cervical cancer screening has significantly contributed to the
declining incidence and mortality of HPV infection and cervical cancer in developed
countries (Cuzick, et al., 2008), this is not the case in developing countries. Similar to the
situation in many developing countries, the rates of HPV vaccination and cervical cancer
screening in Nigeria are not known but presumed to be extremely low (Ndikom & Oboh,
2017; Ogochukwu et al., 2017). Reports from recent investigations indicate fewer than
14% of adolescent girls had received HPV vaccine (Ndikom & Oboh, 2017; Ogochukwu
et al., 2017) and less than 10% of women have been cervical cancer screening (Idowu,
Olowookere, Fagbemi, & Ogunlaja, 2016; Wright et al., 2014). Of particular note, Awodele
and colleagues (2011) also reported poor uptake of cervical screening among nurses, with
60% of the sample of 200 nurses reporting never having been screened for cervical cancer.
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Amplifying this low uptake of cervical cancer screening in Nigeria are a wider
range of personal, social, political and institutional factors. Commonly reported barriers
include lack of awareness, poor knowledge of diseases and preventive measures, lack of
spousal support, misperceptions, stigma and modesty, cultural beliefs and practices, cost
of screening, access to and use of health facilities (Adetule, 2016; Lim & Ojo, 2017;
Ndikom & Ofi, 2012; Ezeonwu, 2014; Modibbo et al., 2016). Furthermore, a woman’s risk
of contracting HPV infection and subsequently developing cervical cancer depends not
only on her own sexual behaviors and practices, but also on those of her male partner(s).
The importance of involving men in reproductive health programs has gained increasing
appreciation since the mid-1990s, given the recognition of the impact of sociocultural
factors on women’s reproductive health. Men play significant roles in reproductive health
through their sexual behaviors, emotional support, family decisions and control of family
resources.
Health education is an effective method of increasing awareness, knowledge, and
utilization of HPV vaccination and cervical cancer screening services (Chigbu, Onyebuchi,
Onyeka, Odugu, & Dim, 2017; Gana, Oche, Ango, Raji, & Okafoagu, 2016; Mbachu, Dim,
& Ezeoke, 2017). Lack of awareness and knowledge and persistent misconceptions about
HPV infection and cervical cancer may contribute to lower levels of perceived
susceptibility and reduced uptake of the preventive measures (Becker, 1974). Interventions
such as community outreach activities, educational fairs, individual mailings, telephone
calls and health care provider reports have been designed to improve HPV vaccination and
cervical cancer screening in different populations and at various levels (Falk, 2018;
Okasako-Schmucker, et al., 2018; Kester, et al., 2014; Krawczyk, et al., 2012). Some
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studies have evaluated community-directed cervical cancer screening interventions in
Nigeria (Abiodun et al., 2014; Odunyemi, Ndikom, & Oluwatosin, 2018). A community
health education nurse-directed 2-day workshop on cervical cancer and HPV vaccination
reported very significant increases (mean score 9.6 ± 7.2 to 21.5 ± 6.2, p<.05) in
knowledge, and more than 93% of mothers who participated were ready to accept HPV
vaccination for their adolescent daughters (Odunyemi, Ndikom, & Oluwatosin, 2018).
Another community-based intervention involving adult women in rural communities
utilized multiple mediums including structured health education, didactic lectures, a movie
and a handbill (pamphlet) to increase awareness of cervical cancer and cervical cancer
screening by 83.1% (Abiodun et al., 2014).
The assessment of the effectiveness of different educational strategies is pertinent
as many health interventions deemed cost-effective are not affordable in developing
countries because of resource limitations (Bilinski, et al., 2017). Adopting low-cost
interventions that maximize health returns is essential in low resource settings. Increasing
universal coverage for interventions with high potential population health benefits is
imperative in public health planning and implementation, especially for low resource
settings, and residents in hard to reach areas. Prior research has shown that increasing
awareness and knowledge of HPV, HPV vaccination, and cervical cancer, and cervical
cancer screening has been effective in increasing both behavioral intention and behavior.
Our aim was to implement an educational intervention, using two strategies, one that could
be efficiently delivered to groups in natural settings such as churches, and one that could
be delivered to individuals who may not be accessible in group settings. Based on the
assumption that some members of the target population would be more accessible and/or
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amenable to a group interventions and others to an individual intervention, two different
intervention strategies that delivered the same content were employed to maximize
population reach. To our knowledge, to date no study has evaluated the efficacy of two,
low cost interventions for improving HPV vaccination and cervical cancer screening in
Nigeria. Therefore, the aim of this research was to evaluate the preliminary efficacy of two
different community-based health education intervention strategies, aimed at improving
awareness and knowledge of: (1) HPV, HPV vaccination, cervical cancer, and cervical
cancer screening, and (2) intention to take and or encourage HPV vaccination and cervical
cancer screening among urban adults in Nigeria.
The research site was Anambra, the eighth most populated state in Nigeria.
Anambra residents have high literacy rates. The state is a highly-urbanized state with 62%
of its population living in urban areas. It is located in the southeastern Nigeria, within an
area of 1,870 mi², and a has a total of 5,366,900 (2013 estimate) inhabitants (National
Population Commission of Nigeria, 2015). The educational interventions and data
collection occurred from December 2017 to January 2018.
Method
This study employed pre-test and post-test design to evaluate the effectiveness of a
community-based health education intervention, a face-to-face presentation delivered in
group settings and printed pamphlet delivered to individuals. Both intervention strategies
involved men and women.
Participants. The study participants were men and women who met the inclusion
criteria and volunteered to participate. The inclusion criteria were adults between the age
of 18 and 65 years who were able to read and write in English. Participants who received
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the face-to-face presentation (Presentation Group), and participants who received a printed
pamphlet (Pamphlet Group) were allocated to groups using convenience sampling based
upon setting, access, and individual preference. Participants recruited in large groups (e.g.
churches, organizations) received face-to-face group-based education while participants
recruited in single groups (e.g., large extended families) or alone received printed
pamphlet-based education. Participation was voluntary and participants in both groups
were given option to choose or reject either of the interventions. Only participants who
completed the pre- and post-intervention surveys were included in the final analysis. A
sample size of 200 participants were estimated. To account for possible attrition, 281
participants were recruited; 168 participants were recruited for the Presentation Group and
113 participants were recruited for the Pamphlet Group.
To recruit participants, individual contacts were made with priests, lay leaders, and
head of organizations, informing them of the study. Churches have been used effectively
in health promotion interventions in communities in Nigeria, where faith has a substantial
role with 87% of people reporting religious service attendance at least once a week
(Ezeanolue, et al., 2015; Ucheaga, & Hartwig, 2010; Abanilla, et al., 2010). At other sites
(e.g., hospitals, educational institution), the primary investigator approached individuals,
and after verifying they met the inclusion criteria, extended an invitation to participate. A
detailed explanation of the objectives, eligibility criteria, confidentiality, and the voluntary
nature of study participation was done. All participants completed the paper-based, selfadministered pre- and post-surveys. Verbal informed consent was obtained, given that it is
more culturally acceptable and appropriate than written consent in Nigeria. Human subject
protection approval was received from the University of South Carolina Institutional
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Review Board for which the primary investigator was affiliated. All data were collected
in a span of four weeks from December 2017 to January 2018.
Intervention. The face-to-face presentation and printed materials were developed
from available educational resources on the Center for Disease Control and Prevention
(CDC) and the Foundation for Women’s Cancer websites (CDC, 2017; Foundation for
Women’s Cancer, 2017). The educational content and presentation materials were adopted
and modified by the primary investigator, a native Nigerian, to be culturally- and
environmentally relevant to the target population. Both modalities had the same content
which included: information on the HPV, HPV vaccine, cervical cancer and cervical cancer
screening, statistical facts on incidence and prevalence of HPV and cervical cancer in
Nigeria as well as the rate of HPV vaccination and cervical cancer screening, and common
misconceptions about HPV, HPV vaccination, cervical cancer and cervical cancer
screening.
The intervention design included three phases. The pre-intervention phase was the
administration of baseline information using the questionnaire. The intervention phase
involved the administration of the health education intervention, in the form of either a
face-to-face health presentation or a printed pamphlet. The total time (including pretest,
intervention and posttest) for participants who received face to face presentations ranged
between 40 and 60 minutes, whereas study participation time for those who received the
pamphlet ranged from 20 to 80 minutes. Among both groups, the post-intervention phase
involved re-administration of the questionnaire immediately following the educational
intervention.
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Survey Instrument. A questionnaire previously developed and used to assess
awareness, knowledge, attitude and practice of HPV and cervical cancer preventive
measures among 352 men in Nigeria was adopted and modified. Survey questions were
based on and/or adapted from other existing surveys, including the Cervical Cancer Free
Coalition National Surveys; Health Information National Trends Survey and previous
studies on HPV and cervical cancer among men in sub-Saharan Africa (Maree, Wright, &
Makua, 2011; Rosser, Zakaras, Hamisi, & Huchko, 2014; Rwamugira, Maree, & Mafutha,
2017; Williams, & Amoateng, 2012). There were two versions of the English-language
survey, one for men and the other for women. The men’s survey contained 44 questions
and the women’s survey consisted of 47 questions. The three additional questions for
women related to decision making. Each version addressed awareness, knowledge,
attitude, intention and stigma. Question format included 4 open-ended questions and 40
and 43 multiple-choice questions for men and women respectively.
Data Analysis Strategies. Data were manually entered into an excel spreadsheet,
crosschecked for correctness, and subsequently analyzed using Statistical Analysis System
(SAS) software version 9.4. Data analysis consisted of descriptive statistics (mean,
frequency and percentage) for socio-demographic variables. Differences between the
demographic characteristics of the two groups were evaluated using t-test and Chi square
statistics. In regard to knowledge of HPV and cervical cancer, a composite score was
computed for each respondent by assigning a score of 1 to each correct answer and 0 to
each wrong answer. Their level of knowledge was scored and categorized as follows: 0-4
is low, 5-9 is fair, 10-13 is high. Descriptive statistics were used to describe group
frequencies pre-and post-test for each intervention group and changes in pre-post
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knowledge changes were assessed independently for each group using ANOVA. The
statistical significance was set at p < 0.05.
Results
Of the 266 participants who completed both the pre-intervention and postintervention questionnaire, 163 were in the Presentation Group and 103 were in the
Pamphlet Group. Socio-demographic characteristics of the participants are shown in Table
3.1. Significant differences were found between the sociodemographic characteristics of
the groups existed in age, sex, educational level and monthly income (p <0.05). The mean
age of the Presentation Group and Pamphlet Group was 35.6 ± 9.64 years and 38.8 ± 10.8
years respectively. More than half of the participants were women (54.0% Presentation
Group and 61.2% Pamphlet Group) and married (59.5% Presentation Group and 71.6%
Pamphlet Group). There were no significant differences in marital status (p=0.2494)
between the two groups. Overall, participants were well-educated, but fewer Presentation
Group participants (71.6%) reported having college education than Pamphlet Group
participants (84.3%). Despite high educational levels, 55.8% of Presentation Group
participants and 36.0% Pamphlet Group participants reported less than 50,000 Nigerian
naira monthly income (equivalent to $139 in the United States). The analysis of the
demographic characteristics showed that the two groups were different, therefore their
knowledge and intention to take HPV vaccine and Cervical Cancer screening were
analyzed separately.
Data on HPV and HPV vaccine knowledge and are presented in Table 3.2. The
groups will be analyzed separately because the participants differ in many of their baseline
characteristics. Only participants who took the pre and posttest were included in the
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analysis. There are differences in the number of responses per item because participants
who had never heard of HPV were told to skip the other HPV knowledge questions.
Table 3.1: Summary of Participant Demographics
Characteristic
Presentation
Group n (%)
Age, years (mean+SD)
35.6+9.64)
Age group (years)
18 -24
5 (3.14)
25 - 34
71 (44.7)
35 - 44
57 (35.9)
45 - 54
18 (11.3)
55 and above
8 (5.03)
Sex
Men
75 (46.0)
Women
88 (54.0)
Marital status
Single
66 (40.5)
Married
97 (59.5)
Educational level
No formal education
0 (0.00)
Primary education
3 (1.85)
Secondary education
43 (26.5)
Tertiary education
116 (71.6)
Monthly income
Less than #50, 000
86 (55.8)
#50-100,000
34 (22.1)
Above #100,000
34 (22.1)

Pamphlet
Group n (%)
38.8+10.8

t-test
0.0168

3 (2.94)
43 (42.2)
23 (22.6)
23 (22.6)
10 (9.80)

0.0370

40 (38.8)
63 (61.2)

0.0427

29 (28.4)
73 (71.6)

0.2494

0 (0.00)
2 (1.94)
14 (13.7)
86 (84.3)

0.0614

36 (36.0)
32 (32.0)
32 (32.0)

0.0054

For the Presentation Group, at pre-intervention, 17.8% of respondents had heard of
HPV infection, whereas on the post-test, 91.4% reported knowledge of HPV infection, and
23.3% knew that HPV is a sexually transmitted virus, with a statistically significant
difference (p < 0.05). Also, less than one-fourth of participants reported knowing that men
and women can contract HPV infection prior to the intervention, whereas at postintervention, more than 82% reported knowledge. At baseline, level of awareness of HPV
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vaccine was 11.8%, which rose to 88.8% at post intervention, with a statistically significant
difference (p<0.05).
About 27.2% of Pamphlet Group respondents had heard of HPV infection at
preintervention, whereas on the post-test, 98.1% reported knowledge of HPV infection
(p < 0.05), as shown in Table 3.2. At baseline, 35.0% knew that HPV is a sexually
transmitted virus, while 98.1% participants reporting awareness of HPV at postintervention
(p < 0.05). Prior to the intervention, 25% of the participants reported knowing that men
and women can contract HPV infection, whereas at post-intervention, more than 82%
reported knowledge. The level of awareness of HPV vaccine was 20.4% at baseline and
increased 85.4% at postintervention (p<0.05).
Table 3.3 presents findings related to participants’ knowledge of cervical cancer
and cervical cancer screening. Similar to HBV knowledge, the two groups were different
at baseline and, therefore, the groups were analyzed separately. The proportion of
Presentation Group participants at pre-intervention, who had heard of cervical cancer was
64.2% and rose to 93.8% at post-intervention (p <0.05). About 36.8% reported knowing
that smoking and multiple sexual partners increases the risk of getting cervical cancer at
baseline, which increased to more than 65% knew post intervention (p < 0.05). Only 25.8%
of Presentation Group participants knew cervical cancer is associated with HPV infection
at baseline, and at post-intervention, more than 85% of participants were aware that
cervical cancer is associated with HPV infection with a significant difference of (p < 0.05).
Additionally, at pre-intervention, among the Presentation Group participants only 13% and
14.9%, respectively had heard of about the pap smear test or VIA, which were statistically
significant (p <0.05) at post-intervention.
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Table 3.2. Participant Knowledge of HPV and HPV Vaccine Pre- and Post-Intervention
Variables
Presentation Group n (%)
Pamphlet Group n (%)
Pre
Post
Post
Pre
P
p
Have you ever heard
of HPV?
No 112(68.7) 8(4.91)
66(64.1) 1(0.97)
Yes 29(17.8) 149(91.4) <.0001 28(27.2) 101(98.1) <.0001
9 (8.74) 1(0.97)
Not sure 22(13.5) 6(3.98)
How do you think
one can get HPV?
Physical contact
6(5.83)
<.0001
Dirty toilets 6(3.68)
17(10.6) <.0001 2(1.94)
4(3.88)
0.0034
Poor personal 12(7.36) 13(7.98) 0.4505 1(0.87)
3(2.91)
0.0678
hygiene 16(9.60) 18(11.0) 0.4670 2(1.94)
101(98.1) <.0001
Sexual intercourse 38(23.3) 151(92.6) <.0001 36(35.0)
How do you know
when someone has
HPV?
Itching
Pain during 18(11.0) 151(92.6) <.0001 10(9.71) 101(98.1) <.0001
10(9.71) 0.0152
urination 10(9.71) 25(15.3) 0.0002 4(3.88)
Genital discharges 15(9.20) 37(22.7) <.0001 14(13.6) 50(48.5) <.0001
Genital rash 16(9.82) 13(7.98) 0.4180 12(11.7) 19(18.5) 0.0396
No symptoms 10(6.13) 103(63.1) <.0001 13(12.6) 33(32.0) <.0001
Who can contract
HPV?
Male only 0(0)
0(0)
9(8.87)
2(1.94)
Female only 11(6.74) 6(3.82)
9(8.87)
13(12.6)
Male and female 41(25.2) 151(96.2) 0.0016 26(25.2) 85(82.5) <.0001
What
factors
increase the risk of
getting HPV?
Poor diet
Smoking 6(3.68)
5(3.07)
0.2124 0(0)
2(1.94)
<.0001
Poor personal 7(4.29)
41(25.2) <.0001 11(10.7) 48(18.1) <.0001
hygiene Multiple 16(9.82) 25(15.4) 0.0024 3(2.91)
5(4.85)
0.0612
sexual partners 39(23.9) 147(90.7) <.0001 33(32.0) 92(89.3) <.0001
Have you heard
about HPV vaccine?
No 133(82.6) 16(9.94)
77(74.8) 9(8.74)
Yes 19(11.8) 143(88.8) <.0001 21(20.4) 88(85.4) <.0001
Not sure 9(5.59)
2(1.24)
5(4.85)
6(5.83)
Who can take the
vaccine?
Boys and girls 14(8.59) 96(58.9) <.0001 15(14.6) 64(62.1) <.0001
Young men and 23(14.4) 103(63.2)
22(21.4) 66(64.1)
women
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For participants in Pamphlet Group, the proportion of participants who had heard
of cervical cancer was 71.8% at baseline and rose to 92.1% at post-intervention. At pre51.3% of the participants reported knowing that smoking and multiple sexual partners
increases the risk of getting cervical cancer (p < 0.05). however, at post-intervention,
51.5% and 89.3% of the participants knew that cervical cancer is associated with and
infection respectively (p < 0.05).
Also, 67.0% of the participants knew cervical cancer is associated with HPV
infection, and 92.2% became aware at postintervention (p < 0.05). Only 37.9% and 31.1%
respectively had heard of the pap smear and HPV tests; which increased to almost 70% and
were statistically significant (p <0.05). Both community-based educational methods
significantly increased participants’ knowledge of cervical cancer and cervical cancer
screening as shown in Table 3.3.
Participants’ Level of Knowledge of HPV and Cervical Cancer. Table 3.4
shows the respondents level of knowledge of HPV and cervical cancer. In the Presentation
Group 85.3% had poor knowledge, 9.82% had moderate and 4.91% had high level of
knowledge of HPV and HPV vaccine, with significant improvements made at postintervention.
Participants in the Pamphlet Group also significantly improved their knowledge of
HPV and HPV vaccine from pre-test to post-test. Those who had high knowledge of HPV
and HPV vaccine increased from 5.88% to 46.6%. In addition, both groups significantly
increased knowledge of cervical cancer and cervical cancer screening as shown below in
Table 3.4.
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Table 3.3 Knowledge of Cervical Cancer and Cervical Cancer screening Pre-intervention
(Pre) and Post intervention (Post).
Variables
Presentation Group n (%)
Pamphlet Group n(%)
Pre
Post
Pre
Post
p
p
Have you ever heard
of cervical cancer?
No 34(21.0) 3(1.86)
25(24.2) 2(1.98)
Yes 104(64.2) 151(93.8) <.0001 74(71.8) 93(92.1) 0.0001
Not sure 24(14.8) 6(5.94)
4(3.88)
6(5.94)
Which
of
the
following do you
think increases the
risk of getting cervical
cancer?
Smoking 40(24.5) 60(36.8) 0.0020 26(25.2) 53(51.5) <.0001
Multiple sexual 62(38.0) 136(83.4) <.0001 71(68.9) 92(89.3)
partners
Do you think cervical
cancer is associated
with an infection? No 51(34.7) 9(5.73)
32(33.0) 8(7.77)
Yes 96(65.3) 148(94.3) <.0001 65(67.0) 95(92.2) <.0001
If yes; what type of
infection is cervical
cancer
associated
with?
42(25.8) 140(85.9) <.0001 57(57.0) 92(89.3) <.0001
HPV infection
Cervical cancer be
prevented?
No 21(14.2) 3(1.92)
11(10.7) 6(5.83)
Yes 127(85.8) 153(98.1) 0.0201 92(89.3) 97(94.2) 0.0082
Early detection of
cervical cancer is
helpful?
No 14(9.21) 6(3.82)
0.0075 6(5.88)
1(1.03)
0.1967
Yes 138(90.8) 151(96.2)
96(94.1) 96(99.0)
Have you heard about
Pap smear test or
Visual Inspection
with Acetic Acid
(VIA)?
No 113(69.8) 11(6.75)
55(53.4) 21(20.4)
Yes 21(13.0) 138(84.7) <.0001 39(37.9) 72(69.9) <.0001
Not sure 28(17.3) 14(8.59)
9(8.74)
10(9.71)
Have you heard about
HPV test?
No 119(73.9) 12(7.50)
55(53.4) 9(8.74)
Yes 24(14.9) 136(85.0) <.0001 32(31.1) 90(87.4) <.0001
Not sure 18(11.2) 12(7.50)
16(15.5) 4(3.88)
Who can take Pap
smear test or VIA or
HPV test?
Women 40(24.5) 137(84.1) <.0001 57(55.9) 92(89.3) <.0001
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Table 3.4: Participants Level of Knowledge of HPV, HPV Vaccine, Cervical Cancer and
Cervical Cancer screening Pre and Post intervention.
Variables
Presentation Group n(%)
Pamphlet Group n(%)
Pre
Post
Pre
Post
p
p
Level of Knowledge
of HPV and HPV
Vaccine.
Poor 139(85.3) 13(7.98)
82(80.4) 20(19.4)
Moderate 16(9.82) 61(37.4) <.0001 14(13.7) 35(34.0) <.0001
High 3(4.91)
89(54.6)
6(5.88)
48(46.6)
Level of Knowledge
of Cervical Cancer
and Cervical Cancer
screening?
Poor 64(39.3) 12(7.36)
21(20.4) 3(2.91)
Moderate 63(38.6) 29(17.8) <.0001 23(22.3) 16(15.5) 0.0002
59(57.3) 84(81.6)
High 36(22.1) 122(74.9)

Reported Uptake of HPV Vaccine and Cervical Cancer Screening at Baseline.
Less than 8% of respondents in both groups had received either the HPV vaccine
themselves or knew of a family member had taken HPV vaccine. Data regarding baseline
uptake of cervical cancer prevention and screening is presented in Table 3.5. As shown,
the number of men and women who had received the HBV vaccination were similar and
there was little difference between groups (p > 0.05). Additionally, very few people in
either group, 5.52% in the Presentation Group and 11.6% in the Pamphlet Group, received
or had a family member who had received a pap smear or VIA test (p > 0.05).
Intention to take and or encourage HPV Vaccine. Table 3.6 presents the study
participants’ intent to receive and or encourage HPV vaccine before and after the
intervention. Participants were asked questions about their willingness to take, encourage
and pay for a family member or their uptake of HPV vaccine. Less than 19% of respondents
in the Presentation group planned to receive HPV vaccine, and only 26.7% were willing to
encourage a family member or friend to receive the HPV vaccine at baseline. At post-
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intervention, 69.1% planned to receive HPV vaccine, and 85.3% were willingness to
encourage a family member or friend to receive the HPV vaccine (p < 0.05 for both preversus post-test). In addition, participants indicating an intent to pay to receive or for a
family member to get HPV vaccine pre-intervention was 31.3% among Presentation Group
participants and increased to 63.4% with a significant difference (p <0.05).
About 18.5% and 45.6% of respondents in the Pamphlet Groups planned to receive
HPV vaccine and were willingness to encourage a family member or friend to receive the
HPV vaccine, respectively, at baseline. Intentions towards HPV vaccination significantly
increased to more than 53% at post-intervention, which was significantly different from
baseline in (p < 0.05). Similarly, participants intent to pay to receive or for a family member
to get HPV vaccine was 40.8% at pre-intervention and rose to more than 73% at postintervention (p <0.05). As shown in Table 3.6, at post-intervention, we observed an
increase in participants’ intent to receive, encourage and pay for HPV vaccine in both
groups.
Table 3.5: HPV Vaccine and Cervical Cancer Screening Rate
Variables
Presentation Group
n(%)
Have you or anyone in your family
had HPV vaccine? If Yes, who?
Me
4 (2.45)
Wife
2 (1.23)
Daughter
0 (0)
Son
0 (0)
Others
2 (1.23)
Nobody
147 (91.8)
Have you or anyone in your
family done a pap smear or VIA
test? If Yes, who?
6 (3.68)
Wife
0 (0.00)
Daughter
3 (1.84)
Others
149 (91.4)
Nobody
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Pamphlet Group
n(%)

2 (1.94)
0 (0)
2 (1.94)
0 (0)
4 (3.88)
95 (92.23)

5 (4.85)
3 (2.91)
4 (3.88)
82 (79.6)

Table 3.6. Intention to encourage and or take HPV Vaccine.
Variables
Presentation Group n(%)
Pamphlet Group n(%)
Pre
Post
Pre
Post
p
P
Do you plan to take
HPV vaccine?
No
Yes
Maybe
Will you encourage
your family member
or friends to take
HPV vaccine?
No
Yes
Maybe
Who will you
encourage to take
HPV vaccine?
Wife
Daughter
Son
Others
Nobody
Will you pay to
receive or for a family
member to get HPV
vaccine, If the vaccine
cost too much?
No
Yes
Maybe

51(31.3)
30(18.4)
82(50.3)

20(12.5)
47(45.6)
112(69.1) <.0001 19(18.5)
30(18.5)
37(35.9)

23(22.3)
55(53.4)
25(24.3)

<.0001

15(9.32) 2(1.23)
15(14.6)
43(26.7) 139(85.3) <.0001 47(45.6)
103(64.0) 22(13.5)
41(39.8)

12(11.7)
7(73.8)
15(14.6)

<.0001

11(14.7)
44(27.0)
36(22.2)
38(23.3)
80(49.1)

45(43.7)
17(10.4)
106(65.0)
49(30.1)
103(63.2) <.0001 26(25.2)
72(44.2)
27(26.2)
20(12.3)
22(21.4)

18(17.5)
83(80.6)
74(71.8)
41(39.8)
8(7.77)

27(16.6)
51(31.3)
85(52.1)

11(6.79)
21(20.4)
109(67.3) <.0001 42(40.8)
42(25.9)
40(38.8)

7(6.93)
64(63.4)
30(29.7)

0.8185
<.0001
<.0001
0.0133

0.0007

Intention to take and or encourage Pap smear or VIA. Similar to other survey
items significant increases were noted in both groups’ intention to receive and willingness
to encourage a family member to receive a screening post-intervention (Table 3.7). Among
the women surveyed in the Presentation Group, 37.5% were planning to receive screening,
and the proportion of respondents willing to encourage family member to receive screening
at baseline was 44.8%. These intentions increased significantly within the Presentation
Group at following the educational intervention (p < 0.05). The proportion of participants
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willing to pay to receive or to pay for a family member to receive a pap smear was 34.0%
at pre-intervention phase, with no significant increase at post-intervention (p > 0.05).
For pamphlet group, 33.3% of the women surveyed were planning to receive
screening, and 51.5% were willing to encourage family member to receive screening at
baseline. However, at post intervention, more than 61% of both participants were planning
to receive screening and were willing to encourage family member to receive screening (p
< 0.05 for both intentions pre- versus post-test). The proportion of participants in the
pamphlet group willing to pay to receive or to pay for a family member to receive a pap
smear was 46.6% at baseline slightly increased (59.2%) at post-intervention, but the
changes was not statistically significant.
Table 3.7. Intention to Encourage and or Take Cervical Cancer Screening.
Variables
Presentation Group n(%)
Pamphlet Group n (%)
Pre
Post
Pre
Post
p
P
Do you plan to go for
cervical cancer
screening (Women
only)?
No
Yes
Not sure
Will you encourage
any of your family
member to receive pap
smear?
No
Yes
Not sure
Will you pay to
receive or for a family
member to receive a
pap smear; if the test
cost too much?
No
Yes
Not sure

23(26.1)
33(37.5)
32(36.4)

4(4.55)
74(84.1)
10(11.4)

34(54.0)
<.0001 21(33.3)
8(12.7)

15(23.8)
39(61.9)
9(14.3)

0.0004

15(9.20)
73(44.8)
75(46.0)

3(1.84)
11(10.7)
138(84.7) <.0001 53(51.5)
22(13.5)
39(37.9)

11(10.7)
81(78.6)
11(10.7)

<.0001

15(9.26)
55(34.0)
92(56.8)

12(7.36)
22(21.4)
119(73.0) <.0001 48(46.6)
32(19.6)
33(32.0)

19(18.5)
61(59.2)
23(22.3)

0.0633
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Logistic regression of factors associated with participants’ level of knowledge
of HPV and cervical cancer. The adjusted model for level of knowledge of HPV and HPV
vaccine is presented in Table 3.8. The adjusted model included age group, marital status,
education and income. For the Presentation group, the odds of increased knowledge of
HPV and HPV vaccine at post intervention for participants between age 18-24 years is 18.1
times higher than the odds of increased knowledge of HPV and HPV vaccine for
participants who are 55 years and older, statistical significant difference. Similarly, the
odds of high knowledge of HPV and HPV vaccine for men is 1.17 times higher than the
odds of high knowledge of HPV and HPV vaccine for women with no statistical significant
difference. Also, no significant difference was observed based on the participants’ marital
status, educational level and monthly income.
For the Participants in the Pamphlet group, the odds of increased knowledge of
HPV and HPV vaccine at post intervention for participants between age 45-54 years is 1.45
times higher than the odds of increased knowledge of HPV and HPV vaccine for
participants who are 55 years and older, with no statistical significant difference. The odds
of increased knowledge of HPV and HPV vaccine were not significantly difference among
participants in the Pamphlet group based on the sex, marital status, educational level and
monthly.
Results of the regression analyses (Table 3.9) indicated the odds of high
knowledge of cervical cancer and cervical cancer screening among participants in various
groups. For the Presentation group, the odds of high knowledge of cervical cancer and
cervical cancer screening for participants aged 18-24 is 18.1 times and 5.7 times for
participants aged 45 to 55 than the odds of high knowledge for those who are 55 years and
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above with significant difference. However, the odds of high knowledge of cervical cancer
and cervical cancer screening were not significantly different among the participants based
on the sex, marital status, educational level and monthly income. Additionally, for the
pamphlet group, the odds of high knowledge of cervical cancer and cervical cancer
screening were not significant among participants based on the age group, sex, marital
status, educational level and monthly income.
Table 3.8: Regression Analysis of Factors Associated with High Knowledge of HPV and
HPV Vaccine.
Presentation Group
Pamphlet Group
Odds 95% CI for OR
ratio
Lower Upper

Odds
ratio

95% CI for OR
Lower Upper

Age Group
18 - 24
25 - 34
35 - 44
45 - 54
55+ (referent)

18.0889
3.7556
2.8739
5.7819

2.4854
0.2555
0.8300
1.4558

131.65
1.6513
9.9512
22.9636

1.4530
3.8089
3.0244
2.2758

0.2893
0.8097
0.6380
0.5400

7.2981
17.9179
14.3365
9.5903

0.6203

2.1944

1.0025

0.5032

1.9974

0.3936

1.5248

0.5160

0.1987

1.3402

0.06190 0.4488
0.4143 1.4568

0.0298
2.3555
1.7533

0.1696
0.6679
0.7635

0.9854
8.3076
4.0261

0.3768
2.1404

0.1594
0.9397

0.8906
4.8752

Sex
Men 1.1667
Women (referent)
Marital Status
Single 0.7746
Married (referent)
Education Level
No formal education
Primary education
Secondary education
Tertiary education
(referent)
Monthly income
(Nigerian Naira)
Less ₦50,000 (referent)
₦50-100,000
Above ₦100,000

0.2146
0.7769

0.8277
2.1735

0.3634
0.9340

1.8853
5.0581
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Table 3.9: Regression Analysis of Factors associated with High Knowledge of Cervical
Cancer and Cervical Cancer Screening.
Presentation Group
Pamphlet Group
Odds 95% CI for OR Odds
95% CI for OR
Ratio Lower Upper
ratio
Lower
Upper
Age group
18 - 24 1.2511 0.2668 5.8680 0.4377
0.1045
1.8335
25 - 34 1.6448 0.4682 5.7784 4.1428
1.2717
13.4960
35 - 44 2.4658 0.8182 7.4318 1.6761
0.4377
6.4176
45 - 54 5.2721 1.4257 19.4956 1.7647
0.5947
5.2369
55+ (referent)
Sex
Men 0.3842 0.2118 0.6971 0.5259
0.2507
1.1033
Women (referent)
Marital status
Single 1.0247 0.5073 2.0699
Married (referent)
Education Level
No formal education
Primary education 0.8375 0.3487 2.0116
Secondary education 0.3418 0.1812 0.6449
Tertiary education
(referent)
Monthly income
(Nigerian Naira)
< ₦50,000 (referent)
₦50-100,000 1.2653 0.6081 2.6330
Above ₦100,00 2.3073 0.9897 5.3789

0.3154

0.1255

0.7930

0.2387
0.01479
0.6495

0.06620
0.005176
0.3468

0.8607
0.04227
1.2161

0.9121
1.4486

0.3537
0.5181

2.3521
4.0503

Discussion
Given that it is important to increase knowledge of HPV and cervical cancer and
engage as many individuals as possible in healthy behavior, offering differing learning
modalities is very vital to increase the reach of educational interventions in an effort to
improve the overall health of a population. To our knowledge, this is the first study to
assess the effectiveness of a community-based intervention that used two educational
intervention strategies to improve awareness and knowledge of HPV, cervical cancer and
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the preventive measures and their intention to engage in and encourage HPV vaccine and
cervical cancer screening in Nigeria. Even though, other studies had utilized various
interventions, presumed to be low cost, they delivered more than one low-cost intervention
per participant, included only women, and/or did not recruit participants from various
locations. The majority of the studies were clinic-based, not community-based.
(Odunyemi, Ndikom, & Oluwatosin, 2018; Ndikom, Ofi, Omokhodion, & Adedokun,
2017). One of the studies that utilized a community-based approach, focused on only rural
women, and assessed only cervical cancer (Abiodun, Olu-Abiodun, Sotunsa, & Oluwole,
2014). The recruitment of participants from various locations in this study, increased the
opportunity to reach individuals who are not associated with groups, such as churches.
Our findings indicate that targeted educational intervention strategies may
contribute to increasing knowledge and intended practices related to HPV vaccination and
cervical cancer screening. The findings are of particular significance considering the high
incidence and prevalence of HPV infection and cervical cancer morbidity and mortality in
Nigeria. Given that increased HPV vaccination coverage to a level of about 70% of the
population can substantially reduce the prevalence of HPV infections, cervical
abnormalities and invasive cervical cancer (WHO, 2009); increasing HPV immunization
awareness, knowledge, and intention are critical. Furthermore, a once-in-a-lifetime
screening of women in between 30 and 50 years of age could reduce the risk of cervical
cancer by 25 to 30% (WHO, 2014).
In this research, both educational modalities (face-to-face group presentation and
educational pamphlets) were effective with in Nigerian adults’ HPV awareness, knowledge
and behavioral intent. At baseline, most participants had very low knowledge levels related
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to HPV infection, cervical cancer, and related preventive measures. Prior research in
Nigeria has indicated low levels of knowledge of HPV and cervical cancer (Jamda, et al.,
2018; Abiodun et al., 2014). In a community-based cervical cancer education initiative
among market women in an urban area of Lagos, Nigeria, Wright, Kuyinu, and Faduyile
(2010) reported that at pre-intervention, over 75% of participants had no knowledge of
cervical cancer pre-intervention. Similarly, Adamu and Colleagues (2012) reported that the
vast majority of the female teachers in Birnin-Kebbi, North-Western Nigeria, who
participated in their study had very low knowledge of cervical cancer at baseline.
Findings from the present study indicated a marked improvement in the proportion
of correct answers to specific questions about the HPV and cervical cancer risk factors,
mode of transmission, symptoms, and methods of prevention and about HPV vaccine and
cervical screening among the participants in both groups after the educational
intervention. More than 82% of the participants in both group correctly answered most
questions. It is important to note that both groups received the same information, but in
different formats (i.e., group presentation or written information). The significant increase
in level of HPV knowledge was similar to other studies carried out in Nigeria (Wright,
Kuyinu, & Faduyile, 2010; Ndikom, Ofi, Omokhodion, & Adedokun, 2017) and other
developing countries (Chang et al., 2013). For example, Adamu, Abiola, and Ibrahim
(2012) noted an improvement of 124.3% in the mean knowledge of cancer of the cervix
score among female teachers exposed to an educational intervention in North-Western
Nigeria (Adamu, Abiola, & Ibrahim, 2012).
Overall, the level of knowledge of participants in both groups improved. In the
Presentation Group, the percentage with poor initial knowledge (85.3%) of HPV and HPV
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Vaccine was reduced to 7.98% and among the Pamphlet Group, there was a similar
reduction in poor initial knowledge from 80.4% to 19.4%. A statistically significant
increase in those with very good knowledge were observed from a very low 4.91% to
54.6% and 5.88% to 46.6% in the Presentation and Pamphlet Groups respectively.
Likewise, for cervical cancer and cervical cancer screening, the proportion of participants
with good knowledge rose from 22.1% to 74.9% in the Presentation Group from 57.3% to
81.6% in the Pamphlet Group B, while those with poor knowledge reduced from 39.3% to
7.36% and 20.4% to 2.91% in the respective groups. This finding is higher than those
reported by Ndikom and colleagues that indicated at baseline 55% of nurses who
participated in the educational intervention had poor knowledge, 30% had fair knowledge,
and only 15% had high level of knowledge, whereas at post-intervention 26.8% had poor
knowledge, 48.3% had fair knowledge and 33.3% had high knowledge (Ndikom, Ofi,
Omokhodion, Bakare, & Adetayo, 2017). However, in their research on Nigerian market
women, Gana and colleagues (2016) reported that initially less than 10% were aware of the
pap smear but that 34% reported increased awareness following the intervention.
The low levels of awareness and knowledge observed at baseline in this research
may have contributed to reported low uptake of HPV vaccine and cervical cancer screening
among family members. Less than 8% of participants reported having received the HPV
vaccine and only 12% reported having a family member who had a pap smear. These
findings are consistent with the research conducted by Mbamara and colleagues that found
over 85% of the women attending gynecology clinics in a tertiary medical center in Southeastern Nigeria had never received cervical screening, despite having attended the
gynecology clinics (Mbamara et al., 2011). Various studies had recorded much lower rates
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of vaccine and screening in different parts of the country. In Abuja, Nigeria, only 1.4% of
mothers reported having a daughter who had received HPV vaccination (Odunyemi,
Ndikom, & Oluwatosin, 2018). Similarly, very low rates (i.e., less than 11%) of cervical
screening service utilization were reported among female health workers in Sokoto (Oche,
Kaoje, Gana, & Ango, 2013), and civil servants in Plateau (Hyacinth, Adekeye, Ibeh, &
Osoba, 2012).
It is important to note that the vast majority of research aimed at assessing the
uptake of HPV vaccination in Nigeria focuses only on girls, despite the fact that the HPV
vaccine is recommended for both boys and girls. Our findings indicated less than 2% of
the respondents reported having a daughter who had been vaccinated and none reported
having a son who had received the vaccine. Odunyemi and colleagues (2018) reported that
85.5% of the mothers they surveyed reported lack of information was a deterrent to having
their daughters take the vaccine. The fact that HPV vaccine frequently is referred to as a
“cervical cancer vaccine” may contribute to limited awareness that the vaccine is also
appropriate for boys. Of note, Jones and colleagues (2016) reported that half of the college
male students were unaware that the HPV vaccine could be given to males. Also, of note,
most published articles in Nigeria tend to address HPV as a virus that causes cervical
cancer, rather than an infection in and of its own right, thus making it seem is only a concern
for women (Odunyemi, Ndikom, & Oluwatosin, 2018; Wright, Kuyinu, & Faduyile, 2010;
Wright, Aiyedehin, Akinyinka, & Ilozumba, 2014).
We also found support for our second objective, which was intention to take and or
encourage HPV vaccine and cervical cancer screening. These findings indicated significant
improvement in reported intent to take and/or encourage HPV vaccination and cervical
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cancer screening among individuals in both groups. Whereas less than 46% of the
respondents were willing to take and or encourage their family member to receive HPV
vaccine and cervical cancer screening at baseline, approximately 73% of participants were
willing to do so post-intervention. These rates are lower than those reported in a study
among antenatal women in Ibadan Nigeria (Ndikom, Ofi, Omokhodion, & Adedokun,
2017), where at baseline, not less than 70% of their participants reported a willingness to
utilize cervical cancer screening services, more than 85% were willing to utilize the
services post-intervention. Similarly, Odunyemi and colleagues (2018) reported that 73.9%
of the mothers who participated in a 2-day workshop were ready to accept HPV vaccination
for their adolescent daughters at baseline, whereas 93.8% were willing to do so 3 months
post-intervention. Among urban residential women in southeast Nigeria, the majority of
participants were reported to be willing to be screened both before and after the intervention
(Mbachu, Dim, & Ezeoke, 2017). The high rate of acceptance of and willingness to
participate in HPV vaccination observed in that study may be attributed to the predominant
acceptance of routine childhood vaccinations among Nigerian men and women.
Exploratory subgroup analyses suggested that younger participants aged (18-24)
were more likely to know about HPV and HPV vaccine. This may be attributed to their
younger age and possible prior personal exposure to HPV vaccination. Of note, there were
no differences associated with marital status, levels of education, or monthly income. In
contrast, Mbachu and colleagues (2017) reported no significant associations between
difference in screening practices and respondents’ age but did find statistical significant
difference with marital status and levels of education. Married women were more likely to
have been screened at least once for cervical cancer than unmarried women as 81.6% of
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the 49 respondents who screened for cervical cancer were married. Further, only those who
had tertiary education had ever screened for cervical cancer (100%). Of note, the odds of
having high knowledge were significant within groups based on their age group, marital
status and level of education. Participants who were single in both groups were more likely
than married participants, and those with tertiary education were more likely than the rest
of the groups to have high knowledge of cervical cancer and cervical cancer screening.
Similar to findings in another study that reported that the odds of screening for cervical
cancer was 5.8 times more in women who had never been married and 3.3 times in married
women (Mbachu, Dim, & Ezeoke, 2017).
Limitations
While the results of this study are very promising, there are some notable
limitations. The study was conducted in urban setting, included only participants who can
read and write in English, and most were college graduates. Further research is needed to
validate the effectiveness of the educational intervention with a different population,
setting, and with different socio-economic backgrounds. The use of a pre-post study design
and relatively small sample size make it necessary for further research on larger sample
using a rigorous research design. The use of immediate pre and posttest method limits the
generalization of the result as the result reflects only short-term cognitive responses. Also,
the participants were not followed up to ascertain their uptake of the preventive measures
and considering that some studies reported poor uptake even with increase awareness,
knowledge and willingness; it will be pertinent to investigate means to encourage uptake
when other factors are positive. The changes overtime were not evaluated, hence the need
for a longitudinal study. Further research should have multiple contacts with participants
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and allow time for recollection of information and observe for uptake of the preventive
measures.
Another limitation is that while the content in both educational interventions was
the same, emphasizing certain aspects of the content was more easily accomplished in the
Presentation modality. For example, post-intervention knowledge of HPV infections being
asymptomatic appears notably more improved in the Presentation Group. That difference
might be attributed to the fact that the asymptomatic characteristic of HPV was repeatedly
emphasized in during the presentation whereas it is stated only once in the pamphlet. Thus,
the intervention strategies that were implemented could likely be further improved upon
and tailored to more effectively deliver the health promotion messages.
Conclusion
These findings of this study, which measured outcomes of a community-based
health education intervention using two educational strategies designed to increase
knowledge and behavioral intent related to HPV vaccination and cervical screening,
provides baseline evidence that low-cost interventions may increase awareness and
knowledge. It is inevitably value-laden that credible evidence is required to reduce the gap
between the health needs and resources available to respond to them. These findings
indicate that targeted health education (face-to-face presentation and printed pamphlet) are
effective approach for improving HPV, cervical cancer and preventive measure awareness
and knowledge, as well as improving intent to participate in HPV vaccination and
screening services. To be effective, HPV health education programs should incorporate the
knowledge, needs, interests, culture, values and beliefs of the target population and address
issues across all levels of prevention. This study was unique in offering both detailed HPV
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infection, cervical cancer and the preventive measures information to men and women
living in urban settings. Earlier intervention studies in Nigeria have focused only on
women, cervical cancer and screening, but this is the first to include men and combine
HPV, cervical cancer and the preventive measures. We found that a large majority of men
and women are willing to take and or encourage HPV vaccination and cervical cancer
screening to their family and friends, if adequate information is provided to them,
consistent with the literatures cited earlier.
Considering the low research funding in developing nations, and the need to assess
people living in hard to reach areas, the evidence has implications for public health
planning and implementation. Relative to use of multiple educational strategies our finding
suggests that educational interventions, delivered via print material or face-to-face group
presentations may be low cost approaches that could be used by non-government and
government programs in low resource settings. Importantly, study results suggest that
group and individual educational strategies that deliver the same content may be effectively
used to reach sub-sets of the population.
Additionally, school-based vaccination may be another way to increase HPV
vaccination. The sexual nature of HPV infection and the psychosocial factors related to
STI, which may have profound effect on uptake vaccine and screening should be
considered when planning interventions to improve uptake. Finally, the inclusion and
participation of men in the study promotes the recommendation to mobilize and educate
men as partners rather than barriers in women’s health. Evidence-informed approaches of
including and working with men are needed to challenge several barriers influencing HPV
vaccination and screening uptake, since men play huge roles in sexual and reproductive
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health in SSA countries. Overall, the study findings lay the groundwork for further
interventions to promote involvement of men in the reduction of HPV and cervical cancer
in Nigeria.
Recommendations
Our findings indicate that increasing public understanding of the virus, its
relationship with cervical cancer and the associated preventive measures are important
steps to improve uptake. The study improved awareness, knowledge, as well as intent to
take and/or encourage HPV vaccination and cervical cancer screening services. Replicating
the study to see if increased knowledge and intention will translate into actual uptake of
HPV vaccination and cervical cancer Screening. Due to our limited sample size,
widespread implementation of at least two educational strategies among different
geographic regions ethnic and religious populations across Nigeria would shed light on the
long-lasting impact of HPV and cervical cancer education. Future research should compare
HPV, cervical cancer and their preventive measures awareness, knowledge and intention
across sexes in Nigeria in order to identify if there are significant differences in awareness,
knowledge and intention. Additional investigations should be conducted among men or
community male leaders only to see if it will mitigate most of the negative psychosocial
barriers in Sub Sahara Africa. There is need for future longitudinal research to evaluate the
effect of various interventions on increasing HPV vaccination and cervical cancer
screening in Nigeria. Though this study was guided by two theories, future research is
needed to use theory to inform the development of interventions. Lastly, it is important to
develop evaluation and feedback tools to assess the effectiveness of the programs and to
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be able to continuously improve the effectiveness of HPV vaccination and cervical cancer
screening interventions and programs.
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CHAPTER 4
ADDRESSING STIGMA AND IMPROVING HPV AND CERVICAL CANCER
KNOWLEDGE IN NIGERIA: ASSESSMENT OF A COMMUNITY-BASED
EDUCATIONAL INTERVENTION
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Introduction
Human papillomavirus (HPV) is the most common viral infection of the
reproductive tract, and a highly prevalent group of viruses among sexually active men and
women worldwide (World Health Organization [WHO], 2018). HPV is mainly transmitted
through sexual contact, but skin-to-skin genital contact is a well-established mode of
transmission (WHO, 2018). The prevalence of HPV among the general population is
unknown in Nigeria, but there are reports of a seroprevalence rate of 43% among women
in the northern state of Birnin-Kebbi (Aminu et al., 2014). Others have reported HPV-IgG
antibodies in over a quarter of the general population in Southern Nigeria (Bruni et al.,
2014; Okolo et al., 2010). Of note, Aminu and colleagues (2014) reported that the HPV
infection was not significantly associated with women’s sexual behavior and found similar
seroprevalence rates among women in both monogamous and polygamous marriages
(Aminu et al., 2014). Furthermore, a link has been established between the HPV status of
men and the risk of cervical cancer in their sexual partners (Bosch et al., 2002; Castellsagué
et al., 2003). HPV is estimated to cause about 5% of human cancers (de Martel et al., 2012;
Bosch et al, 2013); and found to be associated with the development of anogenital cancers
(cervical, vaginal, vulvar, penile, and anal), oropharyngeal cancer, and genital warts (CDC,
2017).
Nigeria has one of the most extensive epidemics of cervical cancer in sub-Saharan
Africa (Ferlay et al., 2014; Oguntayo et al., 2011), with a high incidence and mortality
rates. Cervical cancer is the second most common female cancer in many parts of Nigeria
(Oguntayo et al., 2011), and results in annual death of approximately 14,000 women
(Ogundipe, 2013). Thus, on average, every hour one Nigerian woman dies of cervical
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cancer (Ogundipe, 2013). The vast majority of cervical cancer cases are attributable to HPV
infection, which are preventable. A comprehensive approach that includes prevention (i.e.,
HPV vaccination), effective screening (i.e., Pap smear, Visual Inspection with Acetic Acid
[VIA] and HPV tests), early diagnosis, and treatment can significantly reduce the risks of
HPV infection and cervical cancer. However, in Nigeria the uptake of these preventive
approaches is low (Idowu, Olowookere, Fagbemi, & Ogunlaja, 2016; Wright et al., 2014).
Among the majority of the Nigerian population there are low levels of HPV infection and
cervical cancer knowledge (Ezenwa, Balogun, & Okafor, 2013; Ndikom & Ofi, 2012).
Other barriers to cervical cancer screening include lack of knowledge of the disease and
screening techniques, stigma and modesty, and lack of spousal support (Lim & Ojo, 2017).
This study was guided by the Theory of Gender and Power, which explores the
depths of sexual inequity, gender and power imbalance (Connell, 1987). This theory further
emphasizes social mechanisms that play an active role in maintaining in gender disparities
and inequities in women’s lives. These inequalities and barriers can be economic, physical,
social or personal in nature and operate at the interpersonal and individual levels. Each
social structure constitutes different risk factors and exposures that increase Nigerian
women’s vulnerability to HPV infection and cervical cancer. Spousal support in form of
male involvement is important in addressing these exposures and risk factors (Wingood &
DiClemente, 2000). Wingood and DiClemente (2000) applied Connell’s Theory of Gender
and Power in their examination of HIV-related exposures, risk factors, and interventions,
noting how gender-based inequities contribute to the generation of risk factors that
adversely affect women’s health. Among these are gender discrimination, exclusion,
labeling and stereotypes, which contribute to social stigma (Link & Phelan, 2001;
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Trammell & Morris, 2012). The link between HPV, a sexually transmitted virus, and
cervical cancer could contribute to stigmatization of cervical cancer and possibly to
reluctance to receive HPV vaccine and cervical cancer screening. In their research with
Chinese women in Hong Kong, Lee and colleagues (2007) noted that it was a difficult for
their participants to accept the possibility that any sexual behavior could lead to HPV
infection and subsequently to cervical cancer. Among women who tested positive for HPV
during cervical screening, McCaffery and colleagues (2006) observed feelings of stigma
and shame only when the women were aware that HPV is transmitted through sexual
contact.
The stigma associated with sexually transmitted infections (STI) may create
barriers to information seeking, screening, and treatment (Fortenberry, 2004; Lim & Ojo,
2017). Of note, a higher level of knowledge has been associated with less expressed stigma,
especially in sexually transmitted infections like HIV (Exner et al., 2009). Furthermore,
support from spouses or male community members can be a key motivation for increasing
HPV vaccination and cervical cancer screening especially in male-dominated societies
(Kim et al., 2012; Lim & Ojo, 2017; Lyimo & Beran, 2012). Despite men’s key role in
reproductive and sexual health, HPV and cervical cancer programs in Nigeria have focused
only on women, and to date, no research has examined the stigma-associated with HPV
and cervical cancer. Interventions involving men and addressing stigma are urgently
needed to improve awareness, spousal support, and reduce HPV and cervical cancer stigma
in Nigeria. Therefore, one of the aims of this study was to examine the effectiveness of an
educational intervention in improving knowledge of, and reducing stigma associated with,
HPV and cervical cancer. A further aim was to identify and compare the differences
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between men and women in Nigeria. The study was conducted in Anambra State. Anambra
State the second most densely populated state in Nigeria, with an estimated 2013
population of 5,366,900 (National Population Commission of Nigeria, 2015). A highlyurbanized state, 62% of the population of Anambra is urban and literacy levels are high.
Method
The research aim was to evaluate the impact of an educational intervention on
knowledge and stigma among a sample of urban-dwelling Nigerian men and women. The
University of South Carolina Institutional Review Board reviewed and approved the
research protocols on 12/4/2017. Inclusion criteria were men and women aged 18 to 65
years who were able to read and write in English. Data collection spanned for four weeks
from December 2017 and January 2018. The primary investigator personally recruited
participants from 12 urban locations in Anambra, Nigeria (e.g., churches, businesses,
healthcare institutions) and verbally explained the study purpose, eligibility criteria,
confidentiality, and the voluntary nature of study participation to all potential participants.
Participants recruited from churches and other organizations received information about
the study from the priests, lay leaders, and organizational leaders. Nigeria is a country
where faith has a substantial role with 87% of people reporting religious service attendance
at least once a week, churches have been used effectively in health promotion interventions
(Ezeanolue, et al., 2015; Ucheaga, & Hartwig, 2010; Abanilla, et al., 2010).
Prior research has shown that increasing awareness and knowledge of HPV, HPV
vaccination, and cervical cancer, and cervical cancer screening has been effective in
increasing both behavioral intention and behavior, our aim was to implement an
educational intervention that could be efficiently delivered to groups in natural settings
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such as churches or delivered to individuals who may not be accessible in group settings.
Based on the assumption that some members of the target population would be more
accessible and/or amenable to a group intervention and others to an individual intervention,
two different strategies for delivering the same health education content were employed to
maximize population reach. Participants were given the opportunity to choose between
attending an oral presentation or receiving printed materials.
A total of 281 participants who met the inclusion criteria were enrolled to receive
the intervention and almost 95% (n=266) completed the pretest, intervention and the posttest. Only participants who completed the pre- and post-intervention surveys were included
in the final analysis. The timing of the group presentations was coordinated with, and
approved by, the officials at each site. Consistent with cultural norms in Nigeria, prior to
data collection, the researcher obtained verbal informed consent, rather than written
consent from all participants. Each study participant completed the self-administered paper
questionnaire supplied by the researcher. The survey instrument used had been previously
developed to assess the knowledge, attitude and practice of HPV and cervical cancer
preventive measures among Nigerian men (Nkwonta and Messias, 2018) and was
culturally modified to address gender issues within the context of Nigerian culture. The
original instrument was based on items from Cervical Cancer Free Coalition National
Surveys, Health Information National Trends Survey and previous studies on HPV and
cervical cancer among men in Ghana, Kenya and South Africa (Maree, Wright, & Makua,
2011; Rosser, Zakaras, Hamisi, & Huchko, 2014; Rwamugira, Maree, & Mafutha, 2017;
Williams, & Amoateng, 2012).
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Intervention strategies. The community-based intervention was delivered as
either a face-to-face health education presentation or a printed pamphlet, both containing
identical information on HPV infection, cervical cancer, HPV vaccine and cervical cancer
screenings. We developed the intervention content from the educational materials available
on the Center for Disease Control and Foundation for Women’s Cancer websites (CDC,
2017; Foundation for Women’s Cancer, 2017). We adopted and modified the presentation
of the materials to make them more culturally and environmentally appropriate for the
urban Nigerian population. Pre-intervention, all participants completed the demographic
information section and the self-administered questionnaire consisting of multiple-choice,
open and close-ended items. Subsequently participants either read the educational
pamphlet or listened to an oral presentation by the investigator, followed by completion of
the post-assessment survey.
The educational content covered the following topics: (a) pictorial and introductory
information on the HPV, including statistical facts of HPV incidence in Nigeria, (b)
pictorial and introductory information on the cervix and cervical cancer, including
statistical facts of cervical cancer incidence in Nigeria, (c) introduction of the HPV
vaccination as a protective and preventive method for HPV infection and cervical cancer,
(d) introduction of the cervical cancer screening as a preventive and early detection method
for cervical cancer, (e) information on common misconceptions, (f) availability of HPV
vaccination and cervical cancer screening in local pharmacies and hospitals, and (g) cost
of vaccines and screenings. At post-test, all participants completed the same instrument.
All sessions were personally conducted by the primary investigator.
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Measures and Analysis. The primary outcomes of interest were knowledge of
HPV, HPV vaccine, cervical cancer and cervical cancer screening, and stigma-associated
with HPV and cervical cancer. We also collected sociodemographic information (i.e., age,
marital status, education, and monthly income). Survey data were entered manually into
two excel sheets and cross-checked for correctness. Statistical analysis was conducted
using Statistical Analysis System (SAS) software version 9.4. Descriptive analysis (mean,
frequency and percentage) were used to calculate the socio-demographics and compare the
knowledge and stigma variables at pre-test and post-test. To assess for their level of
knowledge, a composite score was computed for each respondent by assigning a score of
0 to each wrong answer and 1 to each correct answer. Knowledge level was categorized as
follows: low, 0-4; fair, 5-9; high, 10-13. T-tests were used to assess for significant
differences in knowledge and stigma for both groups at pre-test and post-test. Logistic
regression analysis was used to calculate the factors associated with knowledge and stigma
associated with HPV and cervical cancer. Statistical significance was set at a p-value of
<0.05.
Results
Only participants who took the pre- and post-test were included in the analysis. Of
the 266 participants, 114 were men and 147 were women. There are differences in number
of responses by topic because participants who have never heard of HPV and or cervical
cancer were told to skip other HPV and cervical cancer knowledge questions. The sample
of participants (Table 4.1) included nearly equal proportions of men and women with a
mean age of 37.8 +11.1 for men and 36.1 +9.43 for women. The dominant age groups
were individuals between 24-34 and 35-44 years. The majority of the participants were
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married and had tertiary education. There were no statistically significant differences
between men and women in regard to participants’ age, age group, marital status or
educational level. The participants’ monthly income differed significantly by gender, with
more than half the women (56.9%) earning less than 50, 000 Nigerian Naira every month.
Table 4.1: Summary of participants’ characteristics
Characteristic
Men n(%)
Age, years (mean+SD)
37.8 +11.1
Age group (years)
18 -24
4 (3.51)
25 - 34
47 (41.2)
35 - 44
34 (29.8)
45 - 54
18 (15.8)
55 and above
11 (9.65)
Marital status
Single
46 (40.4)
Married
68 (59.7)
Educational level
No formal education
1 (0.88)
Primary education
3 (2.63)
Secondary education
23 (20.2)
Tertiary education
87 (76.3)
Monthly income
Less than #50, 000
39 (36.1)
#50-100,000
31 (28.7)
Above #100,000
38 (35.2)

Women n(%)
36.1 +9.43
4 (2.72)
67 (45.6)
46 (31.3)
23 (15.7)
7 (4.76)

T test
0.2032

0.3065

49 (32.5)
102 (67.5)

0.1887

1 (0.67)
34 (22.7)
115 (76.7)

0.5222

83 (56.9)
35 (24.0)
28 (19.2)

0.0005

Awareness and Knowledge of HPV, Cervical Cancer and the Screening
Measures. Table 4.2 presents data related to participant awareness and knowledge of HPV
and cervical cancer. At baseline, the majority of the men (62.6%) and women (70.2%) had
never heard of HPV; which was reduced to less than 4% at post-intervention; there was no
statistical difference between the two groups (p=0.2659). Similarly, at baseline few
participants (30.2% of men and 25.8% of women) knew that HPV is sexually transmitted,
but at post-intervention, the clear majority of men (95%) and women (94%) had attained
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this knowledge (p <0.05). In terms of knowledge regarding susceptibility to contracting
HPV, there was a significant difference observed between baseline (p >0.05) and post
intervention (p <0.05) responses. Pre-intervention awareness of HPV vaccine was very low
and differed between the two groups (p=0.0055), with 72.6% of men and 84.8% of women
not aware of HPV vaccine. Post-intervention, lack of awareness was less than 10% in both
groups. Furthermore, knowledge of the appropriate age group for HPV vaccine went from
less than 14% at pre-test to 60% at post-intervention in both groups, with no statistically
significant difference between groups (0.9653).
Table 4.3 presents the data related to pre- and post-intervention cervical cancer
awareness and knowledge. There were significant increases in all the measures of cervical
cancer awareness and knowledge. In contract to the awareness and knowledge of HPV and
HPV vaccine, a majority of the participants were aware of cervical cancer. At baseline,
more than 72% and 62% of men and women were aware of cervical cancer, but less than
58% knew that having multiple sexual partners increase the risk of getting cervical cancer.
At baseline there were statistically significant differences in level of awareness of the risk
factors for cervical cancer (0.0043), awareness of cervical cancer being caused by an
infection (0.0073), and awareness of HPV infection as the major cause of cervical cancer
(0.0005) but no statistical differences at post intervention (p>0.05 for all). Although the
majority of the participants were aware of cervical cancer at baseline, very few (20.2% of
men and 24.5% of women) were aware of any type of cervical cancer screenings. After the
targeted educational intervention, awareness of cervical cancer screening increased to
76.5% in men and 80.8% in women (0.0245).
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Table 4.2: Participants Knowledge of HPV and HPV Vaccine
Pre-Intervention n(%)
Post-Intervention n(%)
Variables
Have you ever heard
of HPV?
No
Yes
Not sure
How do you think one
can get HPV?
Physical contact
Dirty toilets
Poor personalhygiene
Sexual intercourse
How do you know
when someone has
HPV?
Itching
Pain during urination
Genital discharges
Genital rash
No symptoms
Who can contract
HPV?
Male only
Female only
Male and female
What factors increase
the risk of getting
HPV?
Poor diet
Smoking
Poor personalhygiene
Many sexual partners
Tick the disease you
think HPV can cause?
Cancer of Anus
Cancer of cervix
Genital warts
Cancer of Penis
Cancerofmouth/throat
Cancer of Vagina
Have you heard about
HPV vaccine?
No
Yes
Not sure
Who can take the
vaccine?
Boys & girls
Young men & women

Men

Women

72(62.6)
31(27.0)
12(10.4)

106(70.2
26(17.2) 0.5255
19(12.6)

4(3.38)
5(3.31)
110(95.7) 140(92.7) 0.2659
1(0.87)
6(3.97)

7(6.09)
7(6.09)
8(6.96)
35(30.2)

1(0.66)
7(4.64)
12(7.95)
39(25.8)

0.0217
0.6075
0.7607
0.4114

14(12.4)
2(1.74)
8(6.96)
110(95.7)

9(5.96)
15(9.93)
13(8.61)
142(94.0)

0.0809
0.0030
0.6175
0.5535

20(17.4)
7(6.09)
13(11.3)
20(17.4)
10(8.70)

8(5.30)
6(3.97)
16(10.6)
8(5.30)
13(8.61)

0.0028
0.4429
0.8556
0.0028
0.9803

12(10.4)
13(11.3)
31(27.0)
16(13.9)
65(56.5)

23(15.2)
17(11.3)
56(37.1)
16(10.6)
71(47.0)

0.2430
0.9907
0.0783
0.4195
0.1253

9(9.38)
11(11.5)
32(33.3)

0
9(9.38)
35(36.5)

0.0056

2(1.80)
12(10.8)
97(87.4)

0
7(4.79)
0.0233
139(95.2)

6(5.22)
4(3.48)
12(10.4)
32(27.8)

0(0)
14(9.27)
7(4.64)
40(26.5)

0.0137
0.0487
0.0840
0.8094

2(1.74)
37(32.2)
14(12.3)
102(89.5)

5(3.31)
52(34.4)
16(10.6)
137(90.7)

0.4103
0.6991
0.6726
0.7371

7(6.09)
27(23.5)
14(12.1)
4(3.51)
9(7.83)
12(10.4)

7(4.64)
33(21.9)
10(6.62)
9(5.96)
11(7.28)
12(7.95)

0.6075
0.7555
0.1324
0.3456
0.8695
0.4922

65(56.5)
89(77.39)
30(26.6)
69(60.5)
56(48.7)
63(54.8)

69(45.7)
124(82.1)
39(25.8)
72(47.7)
66(43.7)
91(60.5)

0.0807
0.3467
0.8957
0.0377
0.4212
0.3728

82(72.6)
20(17.7)
11(9.73)

128(84.8
20(13.3) 0.0055
3(1.99)

12(10.4)
98(85.2)
5(4.35)

13(8.72)
133(89.3) 0.8879
3(2.01)

8(6.96)
19(17.0)

21(13.9)
26(17.2)

69(60.0)
77(67.0)

91(60.3)
92(60.9)
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p

0.0611
0.9570

Men

Women

P

0.9653
0.3110

Table 4.3. Knowledge of Cervical Cancer and Cervical Cancer Screening
Pre-Intervention n(%)
Post-Intervention n(%)
Variables
Have you ever heard
of cervical cancer?
No
Yes
Not sure
Which of the following
do you think increases
the risk of getting
cervical cancer?
Smoking
Multiple sexual
partners
Do you think cervical
cancer is associated
with an infection? No
Yes
If yes; what type of
infection is cervical
cancer
associated
with?
HPV infection
Cervical cancer be
prevented?
No
Yes
Early detection of
cervical cancer is
helpful?
No
Yes
Have you heard about
Pap smear test or
Visual Inspection with
Acetic Acid (VIA)?
No
Yes
Not sure
Have you heard about
No
HPV test?
Yes
Not sure
Who can take Pap
smear test or VIA or
HPV test?
Women

Men

Women

24(21.1)
83(72.8)
7(6.14)

35(23.2)
95(62.9)
21(13.9)

3(2.65)
2(1.34)
0.4076 106(93.8 138(92.6 0.2374
4(3.54)
9(6.04)

26(22.6)
46(40.0)

40(26.5)
87(57.6)

0.4665 42(36.5)
0.0043 94(81.7)

4(43.7)
58(56.3)

38(27.0) 0.0073 7(6.36)
10(6.67) 0.9223
103(73.0
103(93.6 140(93.3

30(26.1)

69(46.6)

0.0005 96(83.5)

17(16.0)
89(84.0)

15(10.3)
130(89.

0.1961

8(7.55)
98(92.5)

12(8.11)
3(2.73)
136(91.9 0.8700 107(97.

4(2.78)
140(97.2 0.9806

74(64.9)
23(20.2)
17(14.9)

94(62.3)
37(24.5)
20(13.3)

21(13.9)
122(80.8 0.0245
8(5.30)

68(60.2)
24(21.2)
21(18.6)

106(70.2
7(6.14)
14(9.40)
32(21.2) 0.0284 100(87.7 126(84.6 0.4670
13(8.61)
7(6.14)
9(6.04)

33(29.0)

64(42.4)
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p

Men

Women

P

71(47.0) 0.0854
134(88.7 0.1166

136(90.

0.2614

4(3.60)
5(3.38)
0.9227
107(96.4 143(96.6

11(9.57)
0.9132 88(76.5)
16(13.9)

0.0229 94(81.7)

135(89.

0.0833

Level of Knowledge of HPV, and Cervical Cancer. Table 4.4 presents data on
the level of HPV and cervical cancer knowledge. Overall, prior to the educational
intervention, respondents’ level of knowledge of HPV, and cervical cancer were low, but
improved at post-test. The majority of participants (81.7% of men and 84.7% of women)
had poor knowledge of HPV and HPV vaccine at baseline. Following the intervention,
participants’ knowledge significantly improved, with poor knowledge persisting among
less than 13%, while nearly 50% had high HPV-related knowledge. At pre-intervention,
the level of cervical cancer knowledge among men and women was significantly different
(0.0012), with no significant differences at post-intervention.
Table 4.4: Participants’ Level of Knowledge of HPV, HPV Vaccine, Cervical Cancer and
Cervical Cancer Screening Pre-Intervention and Post-Intervention
Pre-Intervention n (%)
Post-Intervention n (%)
Variables
Level of Knowledge
of HPV and HPV
Vaccine.
Poor
Moderate
High
Level of Knowledge
of Cervical Cancer
and Cervical Cancer
screening?
Poor
Moderate
High

Men

Women

94(81.7)
17(14.8)
4(3.48)

46(40.0)
40(34.8)
29(25.2)

p

Men

Women

p

127(84.7) 0.9677
13(8.67)
10(6.67)

14(12.2)
39(33.9)
62(53.9)

19(12.6)
57(37.8)
75(49.7)

0.5916

39(25.8)
46(30.5)
66(43.7)

11(9.57)
19(16.5)
85(73.9)

4(2.65)
0.0702
26(17.2)
121(80.1)

0.0012

Stigma Associated with HPV Infection and Cervical Cancer. In terms of stigma
(see Table 4.5), no significant changes were observed pre/posttest in five out of the six
domains; however, there were no statistically sig differences except for “Do you believe
telling someone you have (had) cervical cancer is risky”. Some participants moved from
uncertainty (i.e., “not being sure”) at pre-test to blaming or stigmatizing victims at post-
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test. For example, at pre-test, 11.5% of men and 16.6% of women indicated testing positive
to HPV infection was associated with having multiple sex partners. However, at post-test,
33.9% of men and 32.5% of women agreed that a positive HPV test result did mean the
person had multiple sex partners. Similar response trends were noted in relation to the
perception of individuals with cervical cancer as having had multiple sexual partners.
Of note, gendered perceptions of disclosure of having cervical cancer were not very
different before the intervention but became statistically significant (0.0394) after the
intervention. At pre-test, 20.2% of men and 35.1% of women agreed disclosing ones’ status
is risky, whereas following the educational intervention, 31.3% of men and 43.1% of
women agreed that it is risky for an individual to disclose their status.
Factors associated with high knowledge of HPV and cervical cancer. The
results of logistic regression analyses on knowledge of HPV and HPV vaccine at post
intervention (Table 4.6). The odds of high knowledge of HPV and HPV vaccine is 3.4
times for male participants (ages 45-54) than the odds of high knowledge of HPV and HPV
vaccine for participants who are 55 years and above. The adjusted odds of having high
knowledge of HPV and HPV vaccine is 1.7 times for male single participants and 2.4 times
for those who earn more than 100,000 naira than the odds of married participants and those
who earned less than 50,000 naira respectively. These categories were found to be
statistically different. However, no statistically significant differences were observed based
on their age group, marital status, education and income for the women.
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Table 4.5. Stigma Associated with HPV Infection and Cervical Cancer
Pre-Intervention n(%)
Post-Intervention n(%)
Variables
Men

Women

p

Men

Women

p

22(19.5)
13(11.5)
78(69.0)

34(22.5)
25(16.6)
92(60.9)

0.2729

35(30.4)
39(33.9)
41(35.7)

43(28.5)
49(32.5)
59(39.0)

0.5948

30(26.5)
15(26.5)
68(60.2)

46(30.5)
16(10.6)
89(58.9)

0.6407

43(37.4)
33(28.7)
39(33.9)

47(31.1)
40(26.5)
64(42.4)

0.1624

43(37.7)
7(6.14)
64(56.1)

67(44.4)
20(13.3)
64(42.4)

0.0835

52(45.2) 58(38.4)
26(22.6) 41(27.2)
37(32.20 52(34.4)

0.3982

59(51.8)
10(8.77)
45(39.5)

66(43.7)
28(18.5)
57(37.8)

0.5848

74(64.4)
10(8.70)
31(27.0)

87(57.6)
23(15.2)
41(27.1)

0.5245

48(42.1)
17(14.9)
49(43.0)

67(25.3)
37(14.0)
47(31.1)

0.2068

62(54.4)
20(17.5)
32(28.1)

80(53.0)
30(20.0)
41(27.2)

0.9639

51(44.7)
23(20.2)
40(35.1)

53(35.1)
53(35.1)
45(29.8)

0.6826

54(47.0)
36(31.3)
25(21.7)

47(31.1)
65(43.1)
39(25.8)

0.0394

Do you think people
with HPV infection
sleep with a lot of
different people?
No
Yes
Not sure
Do you think people
with cervical cancer
sleep with a lot of
different people?
No
Yes
Not sure
Do you think people
who have (had)
cervical cancer caused
their problem?
No
Yes
Not sure
Do you think that a
person affected by
cervical cancer is
disgusting?
No
Yes
Not sure
Do you feel
uncomfortable around
someone affected by
cervical cancer?
No
Yes
Not sure
Do you believe telling
someone you have
(had) cervical cancer is
risky?
No
Yes
Not sure
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Table 4.6: Regression Analysis of Factors Associated with High Knowledge of HPV and
HPV Vaccination at Post Intervention
Men
Women
Odds
95% CI for OR Odds
95% CI for OR
Ratio
Lower Upper ratio
Lower Upper
Age group
18 - 24 0.3739 0.05972 2.3408 3.1758
0.3236 31.1711
25 - 34 0.8051 0.4656 1.3921 0.7361
0.4640 1.1678
35 - 44 1.6675 0.8422 3.3017 1.0653
0.6087 1.8645
45 - 54 3.4232 1.1402 10.2775 1.7584
0.7613 4.0614
55+ (referent)
Marital status
Single 1.7276 1.0622 2.8098 1.1548
0.7892 1.6898
Married (referent)
Education Level
No formal education 1292187
0
Infty
Primary education 0.1805 0.02102 1.5507 1.632E-7
0
Infty
Secondary education 0.6113 0.9522 1.3259 0.9694
0.5081 1.8498
Tertiary education
(referent)
Monthly income
(Nigerian Naira)
Less ₦50,000 (referent)
₦50-100,000 0.8099
Above ₦100,00 2.4497

0.4135 1.5865
1.2222 4.9099

1.0108
1.7922

0.5334
0.8367

1.9154
3.8388

Regarding knowledge of cervical cancer and cervical cancer screening at post
intervention (Table 4.7), for participants aged 35-44, the odds of high knowledge
of cervical cancer and cervical cancer screening is 3.6 times for men and 8.1 times for
women than the odd of high knowledge for men and women who were 55 years and above.
Additionally, men had 1.9 times and women had 3.5 times the odds of high knowledge
of cervical cancer and cervical cancer screening than the participants aged 55 years and
above. In terms of marital status, a significant difference was observed. The odds of high
knowledge of cervical cancer and cervical cancer screening for single male participants

86

were 2.1 times and 4 times for single female participants than the odds for married
participants.
Table 4.7: Logistic Regression Estimates (Odds Ratio) of High Knowledge of Cervical
Cancer at Post Intervention.
Men
Women
Odds
95% CI for OR Odds
95% CI for OR
Ratio
Lower Upper ratio
Lower
Upper
Age group
18 - 24 0.4189 0.06733 2.6069 3.2182 0.3258
31.7851
25 - 34 1.9317 1.0640 3.5068 3.5477 1.9945
6.3105
35 - 44 3.6420 1.6136 8.2204 8.1928 3.2415
20.7074
45 - 54 1.7506 0.5236 5.8533 6.8627 2.0162
23.3600
55+ (referent)
Marital status
Single 2.1985 1.1863 4.0745 4.0408 2.0076
8.1331
Married (referent)
Education Level
No formal education 2245761
0
Infty
Primary education 0.2192 0.02544 1.8882 0.4258 0.01135 15.9670
Secondary education 1.1797 0.5326 2.6130 2.4383 1.1708
5.0780
Tertiary education (referent)
Monthly income (Nigerian
Naira)
Less ₦50,000 (referent)
₦50-100,000 2.1751
Above ₦100,00 4.3848

1.0283 4.6005 6.0326
1.9412 9.9047 6.2316

2.3406
2.1353

15.5482
18.1865

Discussion
To the best of our knowledge, this study is the first in Nigeria to compare the
efficacy of an educational intervention in improving levels of awareness and knowledge
of HPV, HPV vaccine, cervical cancer and cervical cancer screening among men and
women and to examine the effect of an educational intervention on stigma associated
with HPV and cervical cancer. These findings indicate that community-based health
education, whether delivered to groups or to individuals, is a promising strategy to
increase HPV and cervical cancer awareness and knowledge among urban-dwelling
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Nigerian men and women. Similar to prior research conducted in other regions of Nigeria
and other countries in sub-Saharan Africa, at pre-intervention we observed low levels of
awareness and knowledge of HPV, cervical cancer and preventive measures (Gana et al.,
2016; Odunyemi, Ndikom, & Oluwatosin, 2018; Rwamugira, Maree, & Mafutha, 2017;
Williams & Amoateng, 2012). A study in Singapore found that only 16% of the sample
of men had ever heard of the HPV (Pitts, et al., 2009). Increased awareness and
knowledge of HPV infection is vital for both men and women, given the significant health
complications of HPV infection in both groups.
Of note, post-intervention awareness and knowledge improved remarkably among
both men and women, with more than 80% correctly answering specific questions about
the risk factors, mode of transmission, and the preventive methods at post-test. Similarly,
Adamu et al., (2012) examined the impact of health information on knowledge of cervical
cancer in North-Western Nigeria and reported a significant difference (p<0.001) in
knowledge with a mean score 63.7% among female teachers who participated in the
intervention. Following a nurse-led educational intervention in Abuja, Nigeria, Odunyemi
and colleagues (2018) reported a significant increase (mean score 9.6 ± 7.2 to 21.5 ± 6.2)
in cervical cancer and HPV knowledge. Prior to the educational intervention, 83.4% of the
participants had poor knowledge of HPV and HPV Vaccine, compared to 12.4% following
the intervention, and those with good knowledge increased from 5.28% to 51.5%
(p <.0001). Among participants with poor knowledge of cervical cancer and cervical
screening, the proportion reduced from 32% to 5.64%, whereas those with very good
knowledge increased from 35.7% to 77.4% (p < 0.0001).
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Community members’ knowledge of the association of HPV as a STI sexually
transmitted infection may impede cervical cancer prevention efforts. The stigma associated
with STIs is increasingly recognized as a critical psychosocial element that may affect
uptake of preventive measures. A study among men in Ghana, found that the most common
belief was that cervical cancer is caused by frequent sex resulting in physical damage
(Williams & Amoateng, 2012). Of note, the proportion of participants in this communitybased research who associated testing positive for HPV infection with having had multiple
sex partners increased significantly after the intervention in both groups, as did the
perception of women diagnosed with cervical cancer. This is similar to the finding by
Fernandez, et al., (2009), who noted men reported they would suspect infidelity by their
partner, if their partner told them she was HPV positive. They also noted that even with
increased understanding that men’s own infidelity could be the cause of their partner's
infection, most men still stated that their first reaction would be to question the woman's
faithfulness.
Of further note is the post-intervention increase of men and women who indicated
individuals with cervical cancer had caused their own problem increased after the
intervention. These findings are consistent with previous research linking awareness of
HPV as sexually transmitted with significantly higher levels of stigma and shame
(McCaffery et al., 2006; Waller, et al., 2007). Similarly, research by Shepherd and Gerend
(2014) reported participants rated a patient with cervical cancer as more dirty, dishonest
and unwise when the cause of the cancer was specified than when it was not specified. The
findings from this research suggest the risk that raising awareness of HPV as a sexually
transmitted infection may potentially increase feelings of stigma and shame among those
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infected. The increased stigma observed in this study indicate that most of the participants
are in Stage 2, unengaged, and stage 3, decision making time, of the Precaution Adoption
Process Model. This means there are significant gaps in their knowledge about HPV and
cervical cancer, including risk and protective factors. Specifically, continuing
dissemination of appropriate, culturally tailored and scientifically sound information
among diverse groups could contribute to the reduction of stigma associated with HPV and
cervical cancer, which over time could contribute to better health outcomes.
Stigma associated with lack of information is a common barrier to disclosure,
particularly in relation to information with sexual connotations. An individual’s ability and
willingness to disclose their status is dependent on the societal perception and feeling
toward HPV and cervical cancer. Following the educational intervention, respondents’
perceptions regarding the risk of disclosing to others that they have cervical cancer
increased in both groups, with more women not being willing to disclose their status. Our
finding revealed a statistically significant difference by gender in some of the key questions
such as who can contract HPV and knowledge of HPV vaccine and cervical cancer at both
preintervention and postintervention. More women than men had more stigmatized belief
about disclosing of status. In contrast, Perrin and colleagues (2006) reported that the
majority (65%) of the women in their study had disclosed their HPV diagnosis to at least
one other person. The finding may be due to internalized stigma associated with social
expectation of women in Nigeria and the patriarchal culture of the society. A permanent
change in awareness, knowledge and stigma associated with HPV and cervical cancer may
be achieved by adequate and sustained health education programs with or without other
interventions. Several strategies for stigma reduction tailored at intrapersonal,
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interpersonal, community and organizational/institutional level are reported in the
literature (Heijnders, & Van Der Meij, 2006; Stangl et al., 2013). These strategies include
counselling, cognitive behavioral therapy, self-help, advocacy and support groups (Stangl
et al., 2013).
Conclusion
Awareness, knowledge, perceptions, and attitudes contribute to women’s exposure
to and susceptibility to HPV infection, and subsequently, to cervical cancer. In Nigeria,
given the high prevalence of HPV infection, there is an associated high prevalence of
cervical cancer. An increase in HPV and cervical cancer morbidity and mortality have
contributed to the urgent need to scale up HPV vaccine and cervical screening efforts. This
research assessed the effectiveness of a community-based educational interventions in
improving HPV awareness and knowledge among urban-dwelling Nigerian men and
women. The untoward finding of increased stigma associated with HPV and cervical
cancer following the educational intervention is not surprising, given that HPV is a sexually
transmitted virus, and as such may be associated with stigma. Given that stigma is a
possible hindrance to the uptake of HPV vaccine and screening, there is an urgent need for
implementing culturally tailored stigma reduction interventions at intrapersonal,
interpersonal, community and organizational/institutional to combat stigma associated
with HPV and cervical cancer. To reduce the negative connotations associated with the
HPV virus using health education, public information should focus on the cause of the
condition, asymptomatic nature of HPV infection, its widespread prevalence, and the fact
that most sexually active people will contract HPV at some point in their lives.
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Limitations
There are several limitations to the methods and implications of this research. We
used a self-administered survey to assess the impact of this tailored, community-based
educational intervention and therefore were not able to identify any causal relationships
between knowledge, attitudes, or practices overtime. Furthermore, the nature of the
convenience sampling and urban setting limits generalizability to the larger Nigerian adult
population. Of note, the majority of the participants were college educated, which is not
representative of the general Nigerian population. Given the research included only
participants who can read and write in English, the sample also does not reflect non-English
speaking Nigerians.
Recommendations for further research
Educational interventions are effective at improving awareness, knowledge and
willingness to participate in preventive and screening services among diverse populations.
However, educational interventions do not necessarily remove or ameliorate structural
barriers to uptake of preventive and screening services. There is a need for further
exploration of the effectiveness of targeted educational interventions in improving HPV
and cervical cancer-related stigma in different circumstances, contexts and settings in SSA.
Further research is warranted to explore and uncover stigma and other emotional factors
that may influence HPV vaccination and screening utilization. It is important to assess HPV
knowledge and attitudes among diverse groups of Nigerian women, men, healthcare
providers and community leaders. To examine sources of stigma and develop culturallytailored strategies to combat the stigma, further research with larger samples of married
men, unmarried men in heterosexual relationship(s) and male community leaders is
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warranted. There is also a need for further research to identify other educational
interventions and approaches to increase male involvement in HPV and cervical cancer
prevention, not only in Nigeria, but in other countries and cultures.
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CHAPTER 5
CONCLUSION AND RECOMMENDATIONS
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Conclusion
The findings from this study support that health education is an effective tool for
increasing awareness, enhancing knowledge and encouraging willingness to engage in
HPV vaccination and screening services among Nigerian adults. Among the 266 urbandwelling Nigerian adults who participated in the study, the majority had low levels of
knowledge of HPV and HPV Vaccine at baseline. However, after exposure to the
community-based educational intervention, knowledge levels clearly increased. Of note,
very few of the 266 participants reported having received the HPV vaccine or having a
family member who had been vaccinated or screened for HPV. Following exposure to the
community-based, culturally tailored educational intervention, there was a clear increase
in reported intent to be vaccinated take and to encourage a family member to receive HPV
vaccination and cervical cancer screening. Of note are the findings related to negativity in
relation to HPV and cervical cancer stigma. We observed negative perception about HPV
and cervical cancer increased with increased knowledge of HPV and cervical cancer. This
may be due to increased awareness on sexual nature of HPV infection, as sexually
transmitted virus has a relationship with stigma. Therefore, increased continuing and
sustained public education on the asymptomatic nature of HPV, its prevalence and that
most sexually active people will contract HPV at some point in their life may help reduce
the negative feeling associated with the virus.
Unique aspects of this research were the inclusion of information on HPV
infection, cervical cancer and the preventive measures to both men and women in urban
settings. Earlier intervention studies in Nigeria have focused solely on women and cervical
cancer and screening (Adamu, Abiola, & Ibrahim, 2012; Abiodun, Olu-Abiodun, Sotunsa,
& Oluwole, 2014; Chigbu, Onyebuchi, Onyeka, Odugu, & Dim, 2017; Gana, Oche, Ango,
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Raji, & Okafoagu, 2016; Mbachu, Dim, & Ezeoke, 2017; Wright, Kuyinu, & Faduyile,
2010; Ndikom et al, 2017; Ndikom, Ofi, Omokhodion & Adedokun, 2017; Odunyemi,
Ndikom, & Oluwatosin, 2018). This research is the first to include men and have a
combined focus on HPV infection, cervical cancer and specific preventive measures (i.e.,
HPV vaccination). Incorporating educational initiatives into community-based, nongovernmental and government-sponsored programs will lead to both increased awareness
and uptake of preventive measures. Other strategies to increase HPV vaccination include
school-based and workplace vaccination opportunities. Possible deterrents to HPV
immunization uptake include the sexual nature of HPV infection and the psychosocial
factors related to sexually transmitted diseases. Health educators and healthcare
professionals must consider these cultural and social factors in planning interventions to
improve HPV immunization uptake.
Of particular note was the importance of men’s participation in this research. This
study serves as an example of the importance of mobilizing and educating men as partners
rather than barriers in relation to women’s health issues. Given men’s roles and influence
in sexual and reproductive health access in SSA, further evidence-informed approaches
that include men as active participants and partners are needed to challenge the multiple
social, economic, and cultural barriers to HPV vaccination and screening uptake. The
findings of this study lay the groundwork for further research-based interventions to
promote involvement of men in the reduction of HPV and cervical cancer in Nigeria. This
study utilized the Theory of Gender and Power, applied to the men and women living in
Anambra. Caution should be taken when generalizing the results to other Nigerians. More

96

research is needed to identify the most effective theory-based interventions for evidencebased nursing practice in this population.
Implications for Nursing Practice
Given that nurses are in a position to effect change and to promote healthy
preventive practices, the study findings are relevant to nursing practice, research and
policy. The positive impact of this targeted educational intervention in improving
awareness, knowledge and intention to take HPV vaccine and cervical cancer screening
among urban Nigerian men suggests that similar initiatives should be developed for other
populations and settings. However, nurses and nurse researchers also need to pay attention
to the gaps in the HPV knowledge, lack of uptake of preventative practices, and stigma
regarding HPV and cervical cancer, in order to develop and implement culturally focused
and tailored interventions to improve HPV vaccine and cervical cancer screening among
diverse populations and settings in Nigeria. Nurses need to be aware of the clinical
implications for population and be prepared to inform and educate both men and women
in Nigeria.
At the individual level, these findings may help inform nursing interventions with
female patients who lack the ability to make health decisions and influence decision
making by involving their significant others. Also, discussing the patient’s beliefs related
to HPV and cervical cancer and perceptions of vulnerability may contribute to reducing the
social stigma related to these diseases. Nurses can facilitate HPV vaccination and screening
uptake by participating in community health events and providing home visits.
Recommending and communicating accurate information to patients is an important role
for nurses. With ongoing rural to urban and international migration, it is important to
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incorporate knowledge of new cultures and languages into nursing curriculums, at both the
baccalaureate and graduate levels, and to expose practicing nurses to various cultures and
sociocultural factors influencing health and illness. More research on HPV and cervical
cancer screening and the application of the Theory of Gender and Power among the
Nigerian population is needed. The current study provided information about the
applicability of the Precaution Adoption Process Model and the Theory of Gender anPower
in knowledge and intention to take HPV vaccination and cervical cancer screening in
Nigeria. Nurses who can access different tribes and region in Nigeria could incorporate
these theories into intervention strategies aimed at increasing the uptake of HPV vaccine
and cervical screening.
Recommendations
Based on the findings of this research, an effective community-based education
program for Nigerian urban-dwelling adults should incorporate information that reflects
the target population’s needs, interests, culture, values and belief. It should also integrate
activities and recommendations related to primary, secondary, and tertiary levels of
prevention. This targeted, culturally-tailored community-based educational intervention
improved awareness, knowledge, and intent to take and or encourage HPV vaccination and
cervical cancer screening services. The findings indicate that both enhancing public
understanding of HPV and the relationship of the virus and cervical cancer and increasing
uptake of effective preventive measures are important steps.
There are several opportunities for future research pertaining to methodology,
content area, and refinement of the conceptual framework. More evidence is required to
further explore the effectiveness of educational interventions in improving HPV and
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cervical cancer-related stigma in different circumstances, contexts and settings in SSA.
Similar research should be conducted with larger and more diverse populations in both
urban and rural areas of Nigeria and further investigators are warranted to assess if
increased knowledge and intention actually translates into increased uptake of HPV
vaccination and other preventive measures.
Due to the geographically limited sample, more widespread implementation among
different geographic regions ethnic and religious populations across Nigeria is warranted
in order to would shed light on the long-lasting impact of HPV and cervical cancer
education. Examples of areas for further investigation include the comparison of HPV
knowledge, attitudes, and intent among more diverse samples of Nigerian men and women.
Further research clearly is warranted in the area of stigma and other emotional factors that
may influence decisions not to participate in HPV vaccination and screening. The roles and
influence of men, particularly male community leaders, also need to be investigated in
order to assess their roles in mitigating psychosocial barriers to HPV vaccination and
screening in diverse areas of SSA.
Further research is necessary to identify other tailored educational interventions to
encourage male participation and inclusion in HPV and cervical cancer prevention has
shown that information without removing the some of the social barriers may not yield the
desired effects. There is a need to review and assess the various interventions used to
increased HPV and cervical cancer knowledge and uptake in Nigeria in order to determine
their reach and effectiveness. Lastly, it is important to develop culturally appropriate
evaluation and feedback tools to assess the effectiveness of the programs and help create
an intervention that is more effective in promoting HPV vaccination and cervical cancer

99

screenings. An understanding of the applicability of the Theory of Gender and Power to
HPV vaccination and cervical cancer screening among in different cultural backgrounds is
needed before planning Theory of Gender and Power interventions.
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APPENDIX A
INFORMED CONSENT FORM
Introduction and Purpose
I am Chigozie Nkwonta, a third year PhD student in the College of Nursing at the
University of South Carolina, USA. You are invited to take part in my study, which is my
dissertation. Before you decide whether or not to take part, it is important for you to
understand why the research is being done and what it will involve. Please take time to
read the following information carefully.
I am conducting an educational intervention to increase HPV and cervical cancer
knowledge and intention to screen for and take HPV vaccine. I want to assess what is
known about HPV and cervical cancer, and if provision of information will increase its
knowledge and intention to take HPV vaccine and cervical cancer screening. You have
been purposively chosen to participate in the study because you live in Anambra state and
is within the age or may have a dependent that is within the age for HPV vaccine and
cervical cancer screening. If you do decide to take part, the rest of this paper contains
information on what to expect. Please read it carefully. I am happy to answer any question
you have about this study before you decide to participate.
Description of Study Procedures
If you choose to participate, the researcher will explain the purpose of the study and a stepby-step procedure for this study. Please, at the end of the information section with the
researcher, feel very free to ask any questions you may have. Then, you will be asked to
give consent. You can give verbal or written consent, depending on what you feel most
comfortable to do.
If you are deemed eligible, you will be enrolled in the study. Once enrolled, you will
complete a questionnaire at the beginning of the study. The questions contain information
that describes you, on HPV, cervical cancer, HPV vaccine and cervical cancer screening.
After completing the questionnaire, the researcher will give a talk on the topics or provide
you with pamphlets contain information on the topics. After listening to the health talk or
reading the pamphlets, you will be given the same questionnaire you filled in the beginning
of the study. If you choose to participate, you do not need to write your name or give any
information that will identify who you are. The questionnaire will be secured in a locked
bag and later entered into a password protected computer. The information you filled on
the questionnaire will be used for my research project. Any identifying information will be
removed. The study is expected to last no longer than 2 hours, 30 minutes.
Risk and Benefits of Participation
There are no known risks associated with this study. However, the questions may cause
you some discomfort since it involves questions about your personal practice of the HPV
and cervical cancer preventive measures. Your participation in this study will increases
your knowledge of HPV, cervical cancer, HPV vaccine and cervical cancer screening.
Also, your participation will help inform more effective approaches to increasing
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knowledge HPV and cervical cancer and uptake of the preventive measures. If you wish to
learn more about the topic confidentially, you can ask further question after the study. I am
willing and ready to answer your questions or enlighten you more on the topic.
Confidentiality
All the information that is collected will be kept strictly confidential. For the purpose of
this study, your personal identification data such as name or ID number is not needed.
However, if any detail that can identify you is written on the questionnaire, it will be
removed when entering the data. An identification number will be assigned to each survey
to protect your identity. All the information collected will be secured and will be destroyed
at the end of my doctoral program.
Voluntary Participation
Your participation in this study is voluntary. If you decide to take part you are still free to
withdraw at any time and without giving a reason. You are also free to refuse to answer
any question. There is no penalty for refusing to participate or dropping from the study.
Contacts
Please let me know if you have any questions before you agree to participate. Please let me
know if you do not understand any question or need more clarification. You may contact
me at (404) 955-6515 or by email cnkwonta@email.sc.edu if you have any study related
questions or problems.
Also, if you have questions or complaints about your treatment as a participant in this study.
If this happens, you may contact the Office of Research Compliance at the University of
South Carolina, Columbia, USA at (803) 777-7095.
Chigozie A. Nkwonta, PhD Candidate, RN/M
College of Nursing
University of South Carolina
Columbia, S.C. 29208

Deanne Hilfinger-Messias, PhD, RN
College of Nursing
University of South Carolina
Columbia, S.C 29208
(803) 576-6021

Signatures/Dates
Your signature indicates you understood the following information:
I have read and understood the project information sheet dated 11/20/2017.
I have been given the opportunity to ask questions about the study.
I agree to take part in the study.
I understand that my taking part is voluntary.
I can withdraw from the study at any time and I will not be asked any questions about
why I no longer want to take part.
I understand my personal details such as name, phone number and address will not be
requested for this study. I will receive a copy of this form.
I will sign this form as a proof of my consent to participate.
Signatures/Dates
_____________________________________
Participants’ Name
_____________________________________
Participants’ Signature/Dates
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APPENDIX B
QUESTIONNAIRE FOR MEN
Section A -Demographic variables
To begin, I am going to ask you a few questions about yourself
1) Age (years)________________________________
2) Marital status- Single_______ Married________ Others________
3) Highest level of education - No formal education_______ Primary education______
Secondary education_______ Tertiary education________
4) Average monthly income (#)- below 50,000____51,000-100,000___above 100,000___
Section B -Human Papilloma Virus (HPV)
5) Have you ever heard of the Human papilloma virus (HPV)? No__ Yes__ Not sure___
IF “yes” or “not sure” continue; if your answer is “no”, please go directly to question
12
6) How do you think one can get HPV (you can choose more than one answer)?
______Physical contact
______Dirty toilets
______Poor personal hygiene
______Sexual intercourse
______I don’t know
7) How do you know if someone has HPV (you can choose more than one answer)?
______Itching in the genital area
______Pain during urination
______Genital discharges
______Genital rash
______No symptoms
______I don’t know
8) Who can contract HPV?
______Male only
______Female only
______Male and female
______I don’t know
9) Which of the following increases the risk of getting HPV (you can choose more than
one answer)?
______Poor diet
______Smoking
______Poor personal hygiene
______Multiple sexual partners
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______I don’t know
10) Tick the disease you think HPV can cause?
______ Cancer of Anus
______ Cancer of cervix
______ Genital warts
______ Cancer of Penis
______ Cancer of mouth and throat
______ Cancer of Vagina
______ I don’t know
11) How likely do you think you or any of your family member will contract HPV?
Not Likely__________ Likely_____________ Very likely____________
12) Have you heard about HPV vaccine? No______ Yes_____ Not sure_______
13) Who can take the vaccine?
______Boys only
______ Girls only
______ Boys and girls
______ Adult men and women
______ Children
______I don’t know
14) Have you or anyone in your family had HPV vaccine, If Yes, who?
Me______ Wife_____ Daughter ______Son______ Others______ None______
15) How important is it for you or your family member to take HPV vaccine?
Very important __________Maybe important_________ Not important ___________
16) Do you plan to take HPV vaccine? No_________ Yes_________ Maybe_________
17) Will you encourage your family member or friends to take HPV vaccine?
No___________ Yes____________ Maybe______________
18) If yes, why will you get or encourage your family member to take up HPV vaccine?
______________________________________________________________________
19) If no, why will you not get or encourage your family member to take up HPV
vaccine?_________________________________________________________________
20) Who will you encourage to take HPV vaccine (you can choose more than one answer)?
Wife____ Daughter _____Son_____ Others_____ None_____
21) Will you pay to receive or for a family member to get HPV vaccine, If the vaccine cost
too much? No___________ Yes____________ Maybe______________
SECTION C: Cervical Cancer
Now I am going to ask you some questions about cervical cancer.
22) Have you ever heard of cervical cancer? No______ Yes______ Not sure__________
23) Which of the following do you think increases the risk of getting cervical cancer (you
can choose more than one answer)?
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______ Lack of personal hygiene
______ Poor diet
______ Hereditary (run in the family)
______ Smoking
______ Multiple sexual partners
______ I don’t know
24) Do you think cervical cancer is associated with an infection? No______ Yes_______
25) If yes in question No 20; what type of infection is cervical cancer associated with?
_______Human immunodeficiency virus (HIV) infection
_______Syphilis infection
_______Human papilloma virus (HPV) infection
_______I don’t know
26) Cervical cancer is a severe disease. No_______ Yes_______
27) Cervical cancer be prevented?
No_______ Yes_______
28) Early detection of cervical cancer is helpful? No_______ Yes_______
29) How likely do you think any of your family member will develop cervical cancer
Not Likely_________ Likely_________ Very likely____________
30) Have you heard about Pap smear test or Visual Inspection with Acetic Acid (VIA)?
No________ Yes_________ Not sure___________
31) Have you heard about HPV test?
No________ Yes________ Not sure________
32) Who can take Pap smear test or VIA or HPV test?
_______Men
_______Women
_______Boys
_______Girls
_______I don’t know
33) Has anyone in your family had a pap smear, If Yes, who? (you can choose more than
one answer)?
Wife_______ Daughter_______ Others_______ None_______
34) How important is it for your family member to take a Pap smear test?
Not important_________ Maybe important_________ Very important____________
35) Will you encourage any of your family member to receive pap smear? No________
Yes_________ Not sure_________
36) If yes, why will you encourage your family member to receive pap smear?
_____________________________________________________________________
37) If no, why will you encourage your family member to receive pap smear?
_____________________________________________________________________
38) Will you pay for a family member to receive a pap smear; if the test cost too much?
No__________ Yes__________ Not sure_____________
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Now I am going to ask you some questions about how you see people who had HPV
infection and cervical cancer
39) Do you think people with HPV infection sleep with a lot of different people?
No_______ Yes_________ Not sure__________
40) Do you think people with cervical cancer sleep with a lot of different people?
No__________ Yes__________ Not sure__________
41) Do you think people who have (had) cervical cancer caused their problem?
No_______ Yes__________ Not sure___________
42) Do you think that a person affected by cervical cancer is disgusting?
No__________ Yes__________ Not sure___________
43) Do you feel uncomfortable around someone affected by cervical cancer?
No__________ Yes_________ Not sure___________
44) Do you believe telling someone you have (had) cervical cancer is risky?
No_________ Yes__________ Not sure___________
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APPENDIX C
QUESTIONNAIRE FOR WOMEN
Section A -Demographic variables
To begin, I am going to ask you a few questions about yourself
1) Age (years)________________________________
2) Marital status- Single_______ Married________ Others________
3) Highest level of education - No formal education________ Primary education______
Secondary education________ Tertiary education________
4) Average monthly income (#)- below 50,000____51,000-100,000___above 100,000___
Section B -Human Papilloma Virus (HPV)
5) Have you ever heard of the Human papilloma virus (HPV)? No___ Yes___ Not sure___
IF “yes” or “not sure” continue; if your answer is “no”, please go directly to question
12
6) How do you think one can get HPV (you can choose more than one answer)?
______Physical contact
______Dirty toilets
______Poor personal hygiene
______Sexual intercourse
______I don’t know
7) How do you know if someone has HPV (you can choose more than one answer)?
______Itching in the genital area
______Pain during urination
______Genital discharges
______Genital rash
______No symptoms
______I don’t know
8) Who can contract HPV?
______Male only
______Female only
______Male and female
______I don’t know
9) Which of the following increases the risk of getting HPV (you can choose more than
one answer)?
______Poor diet
______Smoking
______Poor personal hygiene
______Multiple sexual partners
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______I don’t know
10) Tick the disease you think HPV can cause?
______ Cancer of Anus
______ Cancer of cervix
______ Genital warts
______ Cancer of Penis
______ Cancer of mouth and throat
______ Cancer of Vagina
______ I don’t know
11) How likely do you think you or any of your family member will contract HPV?
Not Likely___________ Likely_____________ Very likely____________
12) Have you heard about HPV vaccine? No_______ Yes______ Not sure_______
13) Who can take the vaccine?
______Boys only
______ Girls only
______ Boys and girls
______ Adult men and women
______ Children
______I don’t know
14) Have you or anyone in your family had HPV vaccine, If Yes, who?
Me______ Husband_____ Son ______ Daughter ______Others _______None______
15) How important is it for you or your family member to take HPV vaccine?
Very important __________Maybe important_________ Not important ___________
16) Do you plan to take HPV vaccine? No_________ Yes_________ Maybe_________
17) Will you encourage your family member to take HPV vaccine?
No___________ Yes____________ Maybe______________
18) If yes, why will you get or encourage your family member to take up HPV vaccine?
______________________________________________________________________
19) If no, why will you not get or encourage your family member to take up HPV
vaccine?_________________________________________________________________
20) Who will you encourage to take HPV vaccine (you can choose more than one answer)?
Daughter _____Son_____ Others_____ None_____
21) Will you pay to receive or for a family member to get HPV vaccine, If the vaccine cost
too much? No____________ Yes_____________ Maybe______________
SECTION C: Cervical Cancer
Now I am going to ask you some questions about cervical cancer.
22) Have you ever heard of cervical cancer? No______ Yes______ Not sure_________
23) Which of the following do you think increases the risk of getting cervical cancer (you
can choose more than one answer)?
______ Lack of personal hygiene
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______ Poor diet
______ Hereditary (run in the family)
______ Smoking
______ Multiple sexual partners
______ I don’t know
24) Do you think cervical cancer is associated with an infection? No______ Yes_______
25) If yes in question No 20; what type of infection is cervical cancer associated with?
_______Human immunodeficiency virus (HIV) infection
_______Syphilis infection
_______Human papilloma virus (HPV) infection
_______I don’t know
26) Cervical cancer is a severe disease. No______ Yes_______
27) Cervical cancer be prevented?
No_______ Yes_______
28) Early detection of cervical cancer is helpful? No______ Yes_______
29) How likely do you think you or any of your family member will develop cervical cancer
Not Likely________ Likely________ Very likely____________
30) Have you heard about Pap smear test or Visual Inspection with Acetic Acid (VIA)?
No________ Yes_________ Not sure___________
31) Have you heard about HPV test?
No________ Yes________ Not sure________
32) Who can take Pap smear test or VIA or HPV test?
_______Men
_______Women
_______Boys
_______Girls
_______I don’t know
33) Have you or anyone in your family had a pap smear, If Yes, who? (you can choose
more than one answer)? Me______ Daughter_______ Others_____ None_______
34) How important is it for you or your family member to take a Pap smear test?
Not important________ Maybe important________ Very important____________
35) Do you plan to go for cervical cancer screening? No_____ Yes____ Not sure_____
36) Will you encourage your family member to go for cervical cancer screening?
No___________ Yes____________ Maybe ______________
37) If yes, why will you encourage your family member to go for cervical cancer screening?
___________________________________________________________
38) If no, why will you encourage your family member to go for cervical cancer
screening? ______________________________________________________________

132

39) Will you pay to receive or for a family member to receive a pap smear; if the test cost
too much? No__________ Yes__________ Not sure____________
40) I can only take HPV vaccine or screening with my husband’s support? No____Yes___
41) I need my husband’s permission to use health care services? No____Yes___
Now I am going to ask you some questions about how you see people who had HPV
infection and cervical cancer
42) Do you think people with HPV infection sleep with a lot of different people?
No_______ Yes_________ Not sure__________
43) Do you think people with cervical cancer sleep with a lot of different people?
No__________ Yes__________ Not sure__________
44) Do you think people who have (had) cervical cancer caused their problem?
No_______ Yes___________ Not sure___________
45) Do you think that a person affected by cervical cancer is disgusting?
No__________ Yes__________ Not sure___________
46) Do you feel uncomfortable around someone affected by cervical cancer?
No__________ Yes_________ Not sure___________
47) Do you believe telling someone you have (had) cervical cancer is risky?
No__________ Yes_________ Not sure________
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